Encounter Well child visit (procedure) 05-11-1966
Condition Risk activity involvement (finding) 05-11-1966
Encounter General examination of patient (procedure) 05-28-1969
Condition Received higher education (finding) 05-28-1969
Encounter General examination of patient (procedure) 06-06-1973
Condition Essential hypertension (disorder) 06-06-1973
Encounter Prenatal initial visit 09-05-2001
Condition Miscarriage in first trimester 09-05-2001
Encounter General examination of patient (procedure) 12-01-2004
Condition Chronic kidney disease stage 1 (disorder) 12-01-2004
Condition Disorder of kidney due to diabetes mellitus (disorder) 12-01-2004
Encounter General examination of patient (procedure) 12-07-2005
Condition Chronic kidney disease stage 2 (disorder) 12-07-2005
Condition Microalbuminuria due to type 2 diabetes mellitus (disorder) 12-07-2005
Encounter Encounter for check up (procedure) 07-25-2012
Encounter Encounter for check up (procedure) 09-26-2012
Encounter General examination of patient (procedure) 01-16-2013
Encounter Encounter for check up (procedure) 06-26-2013
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 06-26-2013
Encounter General examination of patient (procedure) 01-22-2014
Condition Ischemic heart disease (disorder) 01-22-2014
Observation Glucose [Mass/volume] in Serum or Plasma 01-22-2014
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 01-22-2014
Observation Creatinine [Mass/volume] in Serum or Plasma 01-22-2014
Observation Calcium [Mass/volume] in Serum or Plasma 01-22-2014
Observation Sodium [Moles/volume] in Serum or Plasma 01-22-2014
Observation Potassium [Moles/volume] in Serum or Plasma 01-22-2014
Observation Chloride [Moles/volume] in Serum or Plasma 01-22-2014
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 01-22-2014
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 01-22-2014
Observation Appearance of Urine 01-22-2014
Observation Odor of Urine 01-22-2014
Observation Clarity of Urine 01-22-2014
Observation Color of Urine 01-22-2014
Observation Glucose [Mass/volume] in Urine by Test strip 01-22-2014
Observation Glucose [Presence] in Urine by Test strip 01-22-2014
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 01-22-2014
Observation Bilirubin.total [Presence] in Urine by Test strip 01-22-2014
Observation Ketones [Mass/volume] in Urine by Test strip 01-22-2014
Observation Ketones [Presence] in Urine by Test strip 01-22-2014
Observation Specific gravity of Urine by Test strip 01-22-2014
Observation pH of Urine by Test strip 01-22-2014
Observation Protein [Mass/volume] in Urine by Test strip 01-22-2014
Observation Protein [Presence] in Urine by Test strip 01-22-2014
Observation Nitrite [Presence] in Urine by Test strip 01-22-2014
Observation Hemoglobin [Presence] in Urine by Test strip 01-22-2014
Observation Leukocyte esterase [Presence] in Urine by Test strip 01-22-2014
Observation Body Height 01-22-2014
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 01-22-2014
Observation Body Weight 01-22-2014
Observation Body mass index (BMI) [Ratio] 01-22-2014
Observation Blood pressure panel with all children optional 01-22-2014
Observation Heart rate 01-22-2014
Observation Respiratory rate 01-22-2014
Observation Leukocytes [#/volume] in Blood by Automated count 01-22-2014
Observation Erythrocytes [#/volume] in Blood by Automated count 01-22-2014
Observation Hemoglobin [Mass/volume] in Blood 01-22-2014
Observation Hematocrit [Volume Fraction] of Blood by Automated count 01-22-2014
Observation MCV [Entitic volume] by Automated count 01-22-2014
Observation MCH [Entitic mass] by Automated count 01-22-2014
Observation MCHC [Mass/volume] by Automated count 01-22-2014
Observation Erythrocyte distribution width [Entitic volume] by Automated count 01-22-2014
Observation Platelets [#/volume] in Blood by Automated count 01-22-2014
Observation Platelet distribution width [Entitic volume] in Blood by Automated count 01-22-2014
Observation Platelet mean volume [Entitic volume] in Blood by Automated count 01-22-2014
Observation Tobacco smoking status 01-22-2014
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 01-22-2014
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 01-22-2014
Observation Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 01-22-2014
Procedure Medication Reconciliation (procedure) 01-22-2014
Procedure Assessment of health and social care needs (procedure) 01-22-2014
Procedure Depression screening (procedure) 01-22-2014
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 01-22-2014
Procedure Depression screening using Patient Health Questionnaire Nine Item score (procedure) 01-22-2014
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 01-22-2014
MedicationRequest Clopidogrel 75 MG Oral Tablet 01-29-2014
MedicationRequest Simvastatin 20 MG Oral Tablet 01-29-2014
MedicationRequest 24 HR metoprolol succinate 100 MG Extended Release Oral Tablet 01-29-2014
MedicationRequest Nitroglycerin 0.4 MG/ACTUAT Mucosal Spray 01-29-2014
Immunization Influenza, seasonal, injectable, preservative free 01-22-2014
Encounter Encounter for problem (procedure) 02-05-2014
Observation Operative Status 02-05-2014
Procedure Referral to cardiology service (procedure) 02-05-2014
Encounter Encounter for problem (procedure) 02-11-2014
Condition Abnormal findings diagnostic imaging heart+coronary circulat (finding) 02-11-2014
Procedure Consultation for treatment (procedure) 02-11-2014
Procedure Angiography of coronary artery (procedure) 02-11-2014
Procedure Post anesthesia care management (procedure) 02-11-2014
Procedure Referral to cardiology service (procedure) 02-11-2014
Encounter Encounter for check up (procedure) 02-19-2014
Observation Glucose [Mass/volume] in Serum or Plasma 02-19-2014
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 02-19-2014
Observation Creatinine [Mass/volume] in Serum or Plasma 02-19-2014
Observation Calcium [Mass/volume] in Serum or Plasma 02-19-2014
Observation Sodium [Moles/volume] in Serum or Plasma 02-19-2014
Observation Potassium [Moles/volume] in Serum or Plasma 02-19-2014
Observation Chloride [Moles/volume] in Serum or Plasma 02-19-2014
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 02-19-2014
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 02-19-2014
Observation Appearance of Urine 02-19-2014
Observation Odor of Urine 02-19-2014
Observation Clarity of Urine 02-19-2014
Observation Color of Urine 02-19-2014
Observation Glucose [Mass/volume] in Urine by Test strip 02-19-2014
Observation Glucose [Presence] in Urine by Test strip 02-19-2014
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 02-19-2014
Observation Bilirubin.total [Presence] in Urine by Test strip 02-19-2014
Observation Ketones [Mass/volume] in Urine by Test strip 02-19-2014
Observation Ketones [Presence] in Urine by Test strip 02-19-2014
Observation Specific gravity of Urine by Test strip 02-19-2014
Observation pH of Urine by Test strip 02-19-2014
Observation Protein [Mass/volume] in Urine by Test strip 02-19-2014
Observation Protein [Presence] in Urine by Test strip 02-19-2014
Observation Nitrite [Presence] in Urine by Test strip 02-19-2014
Observation Hemoglobin [Presence] in Urine by Test strip 02-19-2014
Observation Leukocyte esterase [Presence] in Urine by Test strip 02-19-2014
Observation Body Height 02-19-2014
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 02-19-2014
Observation Body Weight 02-19-2014
Observation Body mass index (BMI) [Ratio] 02-19-2014
Observation Blood pressure panel with all children optional 02-19-2014
Observation Heart rate 02-19-2014
Observation Respiratory rate 02-19-2014
Observation Tobacco smoking status 02-19-2014
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 02-19-2014
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 02-19-2014
Observation Total score [DAST-10] 02-19-2014
Procedure Assessment of health and social care needs (procedure) 02-19-2014
Procedure Depression screening (procedure) 02-19-2014
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 02-19-2014
Procedure Assessment of substance use (procedure) 02-19-2014
Procedure Screening for drug abuse (procedure) 02-19-2014
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 02-19-2014
Encounter Encounter for problem (procedure) 02-26-2014
Procedure Percutaneous coronary intervention (procedure) 02-26-2014
Encounter General examination of patient (procedure) 01-28-2015
Observation Glucose [Mass/volume] in Serum or Plasma 01-28-2015
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 01-28-2015
Observation Creatinine [Mass/volume] in Serum or Plasma 01-28-2015
Observation Calcium [Mass/volume] in Serum or Plasma 01-28-2015
Observation Sodium [Moles/volume] in Serum or Plasma 01-28-2015
Observation Potassium [Moles/volume] in Serum or Plasma 01-28-2015
Observation Chloride [Moles/volume] in Serum or Plasma 01-28-2015
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 01-28-2015
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 01-28-2015
Observation Appearance of Urine 01-28-2015
Observation Odor of Urine 01-28-2015
Observation Clarity of Urine 01-28-2015
Observation Color of Urine 01-28-2015
Observation Glucose [Mass/volume] in Urine by Test strip 01-28-2015
Observation Glucose [Presence] in Urine by Test strip 01-28-2015
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 01-28-2015
Observation Bilirubin.total [Presence] in Urine by Test strip 01-28-2015
Observation Ketones [Mass/volume] in Urine by Test strip 01-28-2015
Observation Ketones [Presence] in Urine by Test strip 01-28-2015
Observation Specific gravity of Urine by Test strip 01-28-2015
Observation pH of Urine by Test strip 01-28-2015
Observation Protein [Mass/volume] in Urine by Test strip 01-28-2015
Observation Protein [Presence] in Urine by Test strip 01-28-2015
Observation Nitrite [Presence] in Urine by Test strip 01-28-2015
Observation Hemoglobin [Presence] in Urine by Test strip 01-28-2015
Observation Leukocyte esterase [Presence] in Urine by Test strip 01-28-2015
Observation Body Height 01-28-2015
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 01-28-2015
Observation Body Weight 01-28-2015
Observation Body mass index (BMI) [Ratio] 01-28-2015
Observation Blood pressure panel with all children optional 01-28-2015
Observation Heart rate 01-28-2015
Observation Respiratory rate 01-28-2015
Observation Cholesterol [Mass/volume] in Serum or Plasma 01-28-2015
Observation Triglycerides 01-28-2015
Observation Low Density Lipoprotein Cholesterol 01-28-2015
Observation Cholesterol in HDL [Mass/volume] in Serum or Plasma 01-28-2015
Observation Tobacco smoking status 01-28-2015
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 01-28-2015
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 01-28-2015
Observation Total score [DAST-10] 01-28-2015
Procedure Assessment of health and social care needs (procedure) 01-28-2015
Procedure Assessment of anxiety (procedure) 01-28-2015
Procedure Assessment of substance use (procedure) 01-28-2015
Procedure Screening for drug abuse (procedure) 01-28-2015
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 01-28-2015
Immunization Influenza, seasonal, injectable, preservative free 01-28-2015
Encounter Encounter for check up (procedure) 04-15-2015
Observation Glucose [Mass/volume] in Serum or Plasma 04-15-2015
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 04-15-2015
Observation Creatinine [Mass/volume] in Serum or Plasma 04-15-2015
Observation Calcium [Mass/volume] in Serum or Plasma 04-15-2015
Observation Sodium [Moles/volume] in Serum or Plasma 04-15-2015
Observation Potassium [Moles/volume] in Serum or Plasma 04-15-2015
Observation Chloride [Moles/volume] in Serum or Plasma 04-15-2015
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 04-15-2015
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 04-15-2015
Observation Appearance of Urine 04-15-2015
Observation Odor of Urine 04-15-2015
Observation Clarity of Urine 04-15-2015
Observation Color of Urine 04-15-2015
Observation Glucose [Mass/volume] in Urine by Test strip 04-15-2015
Observation Glucose [Presence] in Urine by Test strip 04-15-2015
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 04-15-2015
Observation Bilirubin.total [Presence] in Urine by Test strip 04-15-2015
Observation Ketones [Mass/volume] in Urine by Test strip 04-15-2015
Observation Ketones [Presence] in Urine by Test strip 04-15-2015
Observation Specific gravity of Urine by Test strip 04-15-2015
Observation pH of Urine by Test strip 04-15-2015
Observation Protein [Mass/volume] in Urine by Test strip 04-15-2015
Observation Protein [Presence] in Urine by Test strip 04-15-2015
Observation Nitrite [Presence] in Urine by Test strip 04-15-2015
Observation Hemoglobin [Presence] in Urine by Test strip 04-15-2015
Observation Leukocyte esterase [Presence] in Urine by Test strip 04-15-2015
Observation Body Height 04-15-2015
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 04-15-2015
Observation Body Weight 04-15-2015
Observation Body mass index (BMI) [Ratio] 04-15-2015
Observation Blood pressure panel with all children optional 04-15-2015
Observation Heart rate 04-15-2015
Observation Respiratory rate 04-15-2015
Observation Tobacco smoking status 04-15-2015
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 04-15-2015
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 04-15-2015
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 04-15-2015
Observation Total score [AUDIT-C] 04-15-2015
Procedure Assessment of health and social care needs (procedure) 04-15-2015
Procedure Assessment of anxiety (procedure) 04-15-2015
Procedure Depression screening (procedure) 04-15-2015
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 04-15-2015
Procedure Assessment of substance use (procedure) 04-15-2015
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 04-15-2015
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 04-15-2015
Encounter Encounter for check up (procedure) 11-11-2015
Observation Glucose [Mass/volume] in Serum or Plasma 11-11-2015
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 11-11-2015
Observation Creatinine [Mass/volume] in Serum or Plasma 11-11-2015
Observation Calcium [Mass/volume] in Serum or Plasma 11-11-2015
Observation Sodium [Moles/volume] in Serum or Plasma 11-11-2015
Observation Potassium [Moles/volume] in Serum or Plasma 11-11-2015
Observation Chloride [Moles/volume] in Serum or Plasma 11-11-2015
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 11-11-2015
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 11-11-2015
Observation Appearance of Urine 11-11-2015
Observation Odor of Urine 11-11-2015
Observation Clarity of Urine 11-11-2015
Observation Color of Urine 11-11-2015
Observation Glucose [Mass/volume] in Urine by Test strip 11-11-2015
Observation Glucose [Presence] in Urine by Test strip 11-11-2015
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 11-11-2015
Observation Bilirubin.total [Presence] in Urine by Test strip 11-11-2015
Observation Ketones [Mass/volume] in Urine by Test strip 11-11-2015
Observation Ketones [Presence] in Urine by Test strip 11-11-2015
Observation Specific gravity of Urine by Test strip 11-11-2015
Observation pH of Urine by Test strip 11-11-2015
Observation Protein [Mass/volume] in Urine by Test strip 11-11-2015
Observation Protein [Presence] in Urine by Test strip 11-11-2015
Observation Nitrite [Presence] in Urine by Test strip 11-11-2015
Observation Hemoglobin [Presence] in Urine by Test strip 11-11-2015
Observation Leukocyte esterase [Presence] in Urine by Test strip 11-11-2015
Observation Body Height 11-11-2015
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 11-11-2015
Observation Body Weight 11-11-2015
Observation Body mass index (BMI) [Ratio] 11-11-2015
Observation Blood pressure panel with all children optional 11-11-2015
Observation Heart rate 11-11-2015
Observation Respiratory rate 11-11-2015
Observation Tobacco smoking status 11-11-2015
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 11-11-2015
Observation Total score [HARK] 11-11-2015
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 11-11-2015
Observation Total score [DAST-10] 11-11-2015
Procedure Medication Reconciliation (procedure) 11-11-2015
Procedure Assessment of health and social care needs (procedure) 11-11-2015
Procedure Screening for domestic abuse (procedure) 11-11-2015
Procedure Depression screening (procedure) 11-11-2015
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 11-11-2015
Procedure Assessment of substance use (procedure) 11-11-2015
Procedure Screening for drug abuse (procedure) 11-11-2015
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 11-11-2015
Immunization Influenza, seasonal, injectable, preservative free 11-11-2015
Encounter General examination of patient (procedure) 02-03-2016
Observation Glucose [Mass/volume] in Serum or Plasma 02-03-2016
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 02-03-2016
Observation Creatinine [Mass/volume] in Serum or Plasma 02-03-2016
Observation Calcium [Mass/volume] in Serum or Plasma 02-03-2016
Observation Sodium [Moles/volume] in Serum or Plasma 02-03-2016
Observation Potassium [Moles/volume] in Serum or Plasma 02-03-2016
Observation Chloride [Moles/volume] in Serum or Plasma 02-03-2016
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 02-03-2016
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 02-03-2016
Observation Appearance of Urine 02-03-2016
Observation Odor of Urine 02-03-2016
Observation Clarity of Urine 02-03-2016
Observation Color of Urine 02-03-2016
Observation Glucose [Mass/volume] in Urine by Test strip 02-03-2016
Observation Glucose [Presence] in Urine by Test strip 02-03-2016
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 02-03-2016
Observation Bilirubin.total [Presence] in Urine by Test strip 02-03-2016
Observation Ketones [Mass/volume] in Urine by Test strip 02-03-2016
Observation Ketones [Presence] in Urine by Test strip 02-03-2016
Observation Specific gravity of Urine by Test strip 02-03-2016
Observation pH of Urine by Test strip 02-03-2016
Observation Protein [Mass/volume] in Urine by Test strip 02-03-2016
Observation Protein [Presence] in Urine by Test strip 02-03-2016
Observation Nitrite [Presence] in Urine by Test strip 02-03-2016
Observation Hemoglobin [Presence] in Urine by Test strip 02-03-2016
Observation Leukocyte esterase [Presence] in Urine by Test strip 02-03-2016
Observation Body Height 02-03-2016
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 02-03-2016
Observation Body Weight 02-03-2016
Observation Body mass index (BMI) [Ratio] 02-03-2016
Observation Blood pressure panel with all children optional 02-03-2016
Observation Heart rate 02-03-2016
Observation Respiratory rate 02-03-2016
Observation Tobacco smoking status 02-03-2016
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 02-03-2016
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 02-03-2016
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 02-03-2016
Observation Total score [AUDIT-C] 02-03-2016
Procedure Medication Reconciliation (procedure) 02-03-2016
Procedure Assessment of health and social care needs (procedure) 02-03-2016
Procedure Assessment of anxiety (procedure) 02-03-2016
Procedure Depression screening (procedure) 02-03-2016
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 02-03-2016
Procedure Assessment of substance use (procedure) 02-03-2016
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 02-03-2016
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 02-03-2016
Encounter Encounter for check up (procedure) 03-09-2016
Observation Glucose [Mass/volume] in Serum or Plasma 03-09-2016
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 03-09-2016
Observation Creatinine [Mass/volume] in Serum or Plasma 03-09-2016
Observation Calcium [Mass/volume] in Serum or Plasma 03-09-2016
Observation Sodium [Moles/volume] in Serum or Plasma 03-09-2016
Observation Potassium [Moles/volume] in Serum or Plasma 03-09-2016
Observation Chloride [Moles/volume] in Serum or Plasma 03-09-2016
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 03-09-2016
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 03-09-2016
Observation Appearance of Urine 03-09-2016
Observation Odor of Urine 03-09-2016
Observation Clarity of Urine 03-09-2016
Observation Color of Urine 03-09-2016
Observation Glucose [Mass/volume] in Urine by Test strip 03-09-2016
Observation Glucose [Presence] in Urine by Test strip 03-09-2016
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 03-09-2016
Observation Bilirubin.total [Presence] in Urine by Test strip 03-09-2016
Observation Ketones [Mass/volume] in Urine by Test strip 03-09-2016
Observation Ketones [Presence] in Urine by Test strip 03-09-2016
Observation Specific gravity of Urine by Test strip 03-09-2016
Observation pH of Urine by Test strip 03-09-2016
Observation Protein [Mass/volume] in Urine by Test strip 03-09-2016
Observation Protein [Presence] in Urine by Test strip 03-09-2016
Observation Nitrite [Presence] in Urine by Test strip 03-09-2016
Observation Hemoglobin [Presence] in Urine by Test strip 03-09-2016
Observation Leukocyte esterase [Presence] in Urine by Test strip 03-09-2016
Observation Body Height 03-09-2016
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 03-09-2016
Observation Body Weight 03-09-2016
Observation Body mass index (BMI) [Ratio] 03-09-2016
Observation Blood pressure panel with all children optional 03-09-2016
Observation Heart rate 03-09-2016
Observation Respiratory rate 03-09-2016
Observation Tobacco smoking status 03-09-2016
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 03-09-2016
Observation Total score [DAST-10] 03-09-2016
Procedure Assessment of health and social care needs (procedure) 03-09-2016
Procedure Assessment of substance use (procedure) 03-09-2016
Procedure Screening for drug abuse (procedure) 03-09-2016
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 03-09-2016
Encounter Encounter for check up (procedure) 08-03-2016
Observation Glucose [Mass/volume] in Serum or Plasma 08-03-2016
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 08-03-2016
Observation Creatinine [Mass/volume] in Serum or Plasma 08-03-2016
Observation Calcium [Mass/volume] in Serum or Plasma 08-03-2016
Observation Sodium [Moles/volume] in Serum or Plasma 08-03-2016
Observation Potassium [Moles/volume] in Serum or Plasma 08-03-2016
Observation Chloride [Moles/volume] in Serum or Plasma 08-03-2016
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 08-03-2016
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 08-03-2016
Observation Appearance of Urine 08-03-2016
Observation Odor of Urine 08-03-2016
Observation Clarity of Urine 08-03-2016
Observation Color of Urine 08-03-2016
Observation Glucose [Mass/volume] in Urine by Test strip 08-03-2016
Observation Glucose [Presence] in Urine by Test strip 08-03-2016
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 08-03-2016
Observation Bilirubin.total [Presence] in Urine by Test strip 08-03-2016
Observation Ketones [Mass/volume] in Urine by Test strip 08-03-2016
Observation Ketones [Presence] in Urine by Test strip 08-03-2016
Observation Specific gravity of Urine by Test strip 08-03-2016
Observation pH of Urine by Test strip 08-03-2016
Observation Protein [Mass/volume] in Urine by Test strip 08-03-2016
Observation Protein [Presence] in Urine by Test strip 08-03-2016
Observation Nitrite [Presence] in Urine by Test strip 08-03-2016
Observation Hemoglobin [Presence] in Urine by Test strip 08-03-2016
Observation Leukocyte esterase [Presence] in Urine by Test strip 08-03-2016
Observation Body Height 08-03-2016
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 08-03-2016
Observation Body Weight 08-03-2016
Observation Body mass index (BMI) [Ratio] 08-03-2016
Observation Blood pressure panel with all children optional 08-03-2016
Observation Heart rate 08-03-2016
Observation Respiratory rate 08-03-2016
Observation Tobacco smoking status 08-03-2016
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 08-03-2016
Observation Fall risk total [Morse Fall Scale] 08-03-2016
Observation Fall risk level [Morse Fall Scale] 08-03-2016
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 08-03-2016
Observation Total score [AUDIT-C] 08-03-2016
Procedure Assessment of health and social care needs (procedure) 08-03-2016
Procedure Assessment using Morse Fall Scale (procedure) 08-03-2016
Procedure Depression screening (procedure) 08-03-2016
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 08-03-2016
Procedure Assessment of substance use (procedure) 08-03-2016
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 08-03-2016
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 08-03-2016
Immunization Pneumococcal conjugate PCV 13 08-03-2016
Encounter General examination of patient (procedure) 02-08-2017
Condition Has a criminal record (finding) 02-08-2017
Observation Glucose [Mass/volume] in Serum or Plasma 02-08-2017
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 02-08-2017
Observation Creatinine [Mass/volume] in Serum or Plasma 02-08-2017
Observation Calcium [Mass/volume] in Serum or Plasma 02-08-2017
Observation Sodium [Moles/volume] in Serum or Plasma 02-08-2017
Observation Potassium [Moles/volume] in Serum or Plasma 02-08-2017
Observation Chloride [Moles/volume] in Serum or Plasma 02-08-2017
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 02-08-2017
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 02-08-2017
Observation Appearance of Urine 02-08-2017
Observation Odor of Urine 02-08-2017
Observation Clarity of Urine 02-08-2017
Observation Color of Urine 02-08-2017
Observation Glucose [Mass/volume] in Urine by Test strip 02-08-2017
Observation Glucose [Presence] in Urine by Test strip 02-08-2017
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 02-08-2017
Observation Bilirubin.total [Presence] in Urine by Test strip 02-08-2017
Observation Ketones [Mass/volume] in Urine by Test strip 02-08-2017
Observation Ketones [Presence] in Urine by Test strip 02-08-2017
Observation Specific gravity of Urine by Test strip 02-08-2017
Observation pH of Urine by Test strip 02-08-2017
Observation Protein [Mass/volume] in Urine by Test strip 02-08-2017
Observation Protein [Presence] in Urine by Test strip 02-08-2017
Observation Nitrite [Presence] in Urine by Test strip 02-08-2017
Observation Hemoglobin [Presence] in Urine by Test strip 02-08-2017
Observation Leukocyte esterase [Presence] in Urine by Test strip 02-08-2017
Observation Body Height 02-08-2017
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 02-08-2017
Observation Body Weight 02-08-2017
Observation Body mass index (BMI) [Ratio] 02-08-2017
Observation Blood pressure panel with all children optional 02-08-2017
Observation Heart rate 02-08-2017
Observation Respiratory rate 02-08-2017
Observation Tobacco smoking status 02-08-2017
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 02-08-2017
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 02-08-2017
Observation Fall risk total [Morse Fall Scale] 02-08-2017
Observation Fall risk level [Morse Fall Scale] 02-08-2017
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 02-08-2017
Observation Total score [AUDIT-C] 02-08-2017
Procedure Assessment of health and social care needs (procedure) 02-08-2017
Procedure Assessment of anxiety (procedure) 02-08-2017
Procedure Assessment using Morse Fall Scale (procedure) 02-08-2017
Procedure Depression screening (procedure) 02-08-2017
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 02-08-2017
Procedure Assessment of substance use (procedure) 02-08-2017
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 02-08-2017
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 02-08-2017
Immunization Influenza, seasonal, injectable, preservative free 02-08-2017
Encounter General examination of patient (procedure) 02-14-2018
Observation Glucose [Mass/volume] in Serum or Plasma 02-14-2018
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 02-14-2018
Observation Creatinine [Mass/volume] in Serum or Plasma 02-14-2018
Observation Calcium [Mass/volume] in Serum or Plasma 02-14-2018
Observation Sodium [Moles/volume] in Serum or Plasma 02-14-2018
Observation Potassium [Moles/volume] in Serum or Plasma 02-14-2018
Observation Chloride [Moles/volume] in Serum or Plasma 02-14-2018
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 02-14-2018
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 02-14-2018
Observation Appearance of Urine 02-14-2018
Observation Odor of Urine 02-14-2018
Observation Clarity of Urine 02-14-2018
Observation Color of Urine 02-14-2018
Observation Glucose [Mass/volume] in Urine by Test strip 02-14-2018
Observation Glucose [Presence] in Urine by Test strip 02-14-2018
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 02-14-2018
Observation Bilirubin.total [Presence] in Urine by Test strip 02-14-2018
Observation Ketones [Mass/volume] in Urine by Test strip 02-14-2018
Observation Ketones [Presence] in Urine by Test strip 02-14-2018
Observation Specific gravity of Urine by Test strip 02-14-2018
Observation pH of Urine by Test strip 02-14-2018
Observation Protein [Mass/volume] in Urine by Test strip 02-14-2018
Observation Protein [Presence] in Urine by Test strip 02-14-2018
Observation Nitrite [Presence] in Urine by Test strip 02-14-2018
Observation Hemoglobin [Presence] in Urine by Test strip 02-14-2018
Observation Leukocyte esterase [Presence] in Urine by Test strip 02-14-2018
Observation Body Height 02-14-2018
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 02-14-2018
Observation Body Weight 02-14-2018
Observation Body mass index (BMI) [Ratio] 02-14-2018
Observation Blood pressure panel with all children optional 02-14-2018
Observation Heart rate 02-14-2018
Observation Respiratory rate 02-14-2018
Observation Cholesterol [Mass/volume] in Serum or Plasma 02-14-2018
Observation Triglycerides 02-14-2018
Observation Low Density Lipoprotein Cholesterol 02-14-2018
Observation Cholesterol in HDL [Mass/volume] in Serum or Plasma 02-14-2018
Observation Tobacco smoking status 02-14-2018
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 02-14-2018
Observation Fall risk total [Morse Fall Scale] 02-14-2018
Observation Fall risk level [Morse Fall Scale] 02-14-2018
Observation Total score [HARK] 02-14-2018
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 02-14-2018
Observation Total score [AUDIT-C] 02-14-2018
Procedure Medication Reconciliation (procedure) 02-14-2018
Procedure Assessment of health and social care needs (procedure) 02-14-2018
Procedure Assessment using Morse Fall Scale (procedure) 02-14-2018
Procedure Screening for domestic abuse (procedure) 02-14-2018
Procedure Depression screening (procedure) 02-14-2018
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 02-14-2018
Procedure Assessment of substance use (procedure) 02-14-2018
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 02-14-2018
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 02-14-2018
Immunization Influenza, seasonal, injectable, preservative free 02-14-2018
Immunization pneumococcal polysaccharide vaccine, 23 valent 02-14-2018
Encounter Encounter for check up (procedure) 08-29-2018
Condition Chronic kidney disease stage 3 (disorder) 08-29-2018
Condition Proteinuria due to type 2 diabetes mellitus (disorder) 08-29-2018
Observation Glucose [Mass/volume] in Serum or Plasma 08-29-2018
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 08-29-2018
Observation Creatinine [Mass/volume] in Serum or Plasma 08-29-2018
Observation Calcium [Mass/volume] in Serum or Plasma 08-29-2018
Observation Sodium [Moles/volume] in Serum or Plasma 08-29-2018
Observation Potassium [Moles/volume] in Serum or Plasma 08-29-2018
Observation Chloride [Moles/volume] in Serum or Plasma 08-29-2018
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 08-29-2018
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 08-29-2018
Observation Appearance of Urine 08-29-2018
Observation Odor of Urine 08-29-2018
Observation Clarity of Urine 08-29-2018
Observation Color of Urine 08-29-2018
Observation Glucose [Mass/volume] in Urine by Test strip 08-29-2018
Observation Glucose [Presence] in Urine by Test strip 08-29-2018
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 08-29-2018
Observation Bilirubin.total [Presence] in Urine by Test strip 08-29-2018
Observation Ketones [Mass/volume] in Urine by Test strip 08-29-2018
Observation Ketones [Presence] in Urine by Test strip 08-29-2018
Observation Specific gravity of Urine by Test strip 08-29-2018
Observation pH of Urine by Test strip 08-29-2018
Observation Protein [Mass/volume] in Urine by Test strip 08-29-2018
Observation Protein [Presence] in Urine by Test strip 08-29-2018
Observation Nitrite [Presence] in Urine by Test strip 08-29-2018
Observation Hemoglobin [Presence] in Urine by Test strip 08-29-2018
Observation Leukocyte esterase [Presence] in Urine by Test strip 08-29-2018
Observation Body Height 08-29-2018
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 08-29-2018
Observation Body Weight 08-29-2018
Observation Body mass index (BMI) [Ratio] 08-29-2018
Observation Blood pressure panel with all children optional 08-29-2018
Observation Heart rate 08-29-2018
Observation Respiratory rate 08-29-2018
Observation Tobacco smoking status 08-29-2018
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 08-29-2018
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 08-29-2018
Observation Fall risk total [Morse Fall Scale] 08-29-2018
Observation Fall risk level [Morse Fall Scale] 08-29-2018
Observation Total score [HARK] 08-29-2018
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 08-29-2018
Procedure Assessment of health and social care needs (procedure) 08-29-2018
Procedure Assessment of anxiety (procedure) 08-29-2018
Procedure Assessment using Morse Fall Scale (procedure) 08-29-2018
Procedure Screening for domestic abuse (procedure) 08-29-2018
Procedure Depression screening (procedure) 08-29-2018
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 08-29-2018
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 08-29-2018
Encounter Encounter for check up (procedure) 01-23-2019
Observation Glucose [Mass/volume] in Serum or Plasma 01-23-2019
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 01-23-2019
Observation Creatinine [Mass/volume] in Serum or Plasma 01-23-2019
Observation Calcium [Mass/volume] in Serum or Plasma 01-23-2019
Observation Sodium [Moles/volume] in Serum or Plasma 01-23-2019
Observation Potassium [Moles/volume] in Serum or Plasma 01-23-2019
Observation Chloride [Moles/volume] in Serum or Plasma 01-23-2019
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 01-23-2019
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 01-23-2019
Observation Appearance of Urine 01-23-2019
Observation Odor of Urine 01-23-2019
Observation Clarity of Urine 01-23-2019
Observation Color of Urine 01-23-2019
Observation Glucose [Mass/volume] in Urine by Test strip 01-23-2019
Observation Glucose [Presence] in Urine by Test strip 01-23-2019
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 01-23-2019
Observation Bilirubin.total [Presence] in Urine by Test strip 01-23-2019
Observation Ketones [Mass/volume] in Urine by Test strip 01-23-2019
Observation Ketones [Presence] in Urine by Test strip 01-23-2019
Observation Specific gravity of Urine by Test strip 01-23-2019
Observation pH of Urine by Test strip 01-23-2019
Observation Protein [Mass/volume] in Urine by Test strip 01-23-2019
Observation Protein [Presence] in Urine by Test strip 01-23-2019
Observation Nitrite [Presence] in Urine by Test strip 01-23-2019
Observation Hemoglobin [Presence] in Urine by Test strip 01-23-2019
Observation Leukocyte esterase [Presence] in Urine by Test strip 01-23-2019
Observation Body Height 01-23-2019
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 01-23-2019
Observation Body Weight 01-23-2019
Observation Body mass index (BMI) [Ratio] 01-23-2019
Observation Blood pressure panel with all children optional 01-23-2019
Observation Heart rate 01-23-2019
Observation Respiratory rate 01-23-2019
Observation Leukocytes [#/volume] in Blood by Automated count 01-23-2019
Observation Erythrocytes [#/volume] in Blood by Automated count 01-23-2019
Observation Hemoglobin [Mass/volume] in Blood 01-23-2019
Observation Hematocrit [Volume Fraction] of Blood by Automated count 01-23-2019
Observation MCV [Entitic volume] by Automated count 01-23-2019
Observation MCH [Entitic mass] by Automated count 01-23-2019
Observation MCHC [Mass/volume] by Automated count 01-23-2019
Observation Erythrocyte distribution width [Entitic volume] by Automated count 01-23-2019
Observation Platelets [#/volume] in Blood by Automated count 01-23-2019
Observation Platelet distribution width [Entitic volume] in Blood by Automated count 01-23-2019
Observation Platelet mean volume [Entitic volume] in Blood by Automated count 01-23-2019
Observation Tobacco smoking status 01-23-2019
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 01-23-2019
Observation Fall risk total [Morse Fall Scale] 01-23-2019
Observation Fall risk level [Morse Fall Scale] 01-23-2019
Observation Total score [DAST-10] 01-23-2019
Procedure Assessment of health and social care needs (procedure) 01-23-2019
Procedure Assessment using Morse Fall Scale (procedure) 01-23-2019
Procedure Assessment of substance use (procedure) 01-23-2019
Procedure Screening for drug abuse (procedure) 01-23-2019
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 01-23-2019
Immunization Influenza, seasonal, injectable, preservative free 01-23-2019
Encounter General examination of patient (procedure) 02-20-2019
Observation Glucose [Mass/volume] in Serum or Plasma 02-20-2019
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 02-20-2019
Observation Creatinine [Mass/volume] in Serum or Plasma 02-20-2019
Observation Calcium [Mass/volume] in Serum or Plasma 02-20-2019
Observation Sodium [Moles/volume] in Serum or Plasma 02-20-2019
Observation Potassium [Moles/volume] in Serum or Plasma 02-20-2019
Observation Chloride [Moles/volume] in Serum or Plasma 02-20-2019
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 02-20-2019
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 02-20-2019
Observation Appearance of Urine 02-20-2019
Observation Odor of Urine 02-20-2019
Observation Clarity of Urine 02-20-2019
Observation Color of Urine 02-20-2019
Observation Glucose [Mass/volume] in Urine by Test strip 02-20-2019
Observation Glucose [Presence] in Urine by Test strip 02-20-2019
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 02-20-2019
Observation Bilirubin.total [Presence] in Urine by Test strip 02-20-2019
Observation Ketones [Mass/volume] in Urine by Test strip 02-20-2019
Observation Ketones [Presence] in Urine by Test strip 02-20-2019
Observation Specific gravity of Urine by Test strip 02-20-2019
Observation pH of Urine by Test strip 02-20-2019
Observation Protein [Mass/volume] in Urine by Test strip 02-20-2019
Observation Protein [Presence] in Urine by Test strip 02-20-2019
Observation Nitrite [Presence] in Urine by Test strip 02-20-2019
Observation Hemoglobin [Presence] in Urine by Test strip 02-20-2019
Observation Leukocyte esterase [Presence] in Urine by Test strip 02-20-2019
Observation Body Height 02-20-2019
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 02-20-2019
Observation Body Weight 02-20-2019
Observation Body mass index (BMI) [Ratio] 02-20-2019
Observation Blood pressure panel with all children optional 02-20-2019
Observation Heart rate 02-20-2019
Observation Respiratory rate 02-20-2019
Observation Tobacco smoking status 02-20-2019
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 02-20-2019
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 02-20-2019
Observation Fall risk total [Morse Fall Scale] 02-20-2019
Observation Fall risk level [Morse Fall Scale] 02-20-2019
Procedure Assessment of health and social care needs (procedure) 02-20-2019
Procedure Assessment of anxiety (procedure) 02-20-2019
Procedure Assessment using Morse Fall Scale (procedure) 02-20-2019
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 02-20-2019
Encounter Encounter for check up (procedure) 03-27-2019
Observation Glucose [Mass/volume] in Serum or Plasma 03-27-2019
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 03-27-2019
Observation Creatinine [Mass/volume] in Serum or Plasma 03-27-2019
Observation Calcium [Mass/volume] in Serum or Plasma 03-27-2019
Observation Sodium [Moles/volume] in Serum or Plasma 03-27-2019
Observation Potassium [Moles/volume] in Serum or Plasma 03-27-2019
Observation Chloride [Moles/volume] in Serum or Plasma 03-27-2019
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 03-27-2019
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 03-27-2019
Observation Appearance of Urine 03-27-2019
Observation Odor of Urine 03-27-2019
Observation Clarity of Urine 03-27-2019
Observation Color of Urine 03-27-2019
Observation Glucose [Mass/volume] in Urine by Test strip 03-27-2019
Observation Glucose [Presence] in Urine by Test strip 03-27-2019
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 03-27-2019
Observation Bilirubin.total [Presence] in Urine by Test strip 03-27-2019
Observation Ketones [Mass/volume] in Urine by Test strip 03-27-2019
Observation Ketones [Presence] in Urine by Test strip 03-27-2019
Observation Specific gravity of Urine by Test strip 03-27-2019
Observation pH of Urine by Test strip 03-27-2019
Observation Protein [Mass/volume] in Urine by Test strip 03-27-2019
Observation Protein [Presence] in Urine by Test strip 03-27-2019
Observation Nitrite [Presence] in Urine by Test strip 03-27-2019
Observation Hemoglobin [Presence] in Urine by Test strip 03-27-2019
Observation Leukocyte esterase [Presence] in Urine by Test strip 03-27-2019
Observation Body Height 03-27-2019
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 03-27-2019
Observation Body Weight 03-27-2019
Observation Body mass index (BMI) [Ratio] 03-27-2019
Observation Blood pressure panel with all children optional 03-27-2019
Observation Heart rate 03-27-2019
Observation Respiratory rate 03-27-2019
Observation Tobacco smoking status 03-27-2019
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 03-27-2019
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 03-27-2019
Observation Fall risk total [Morse Fall Scale] 03-27-2019
Observation Fall risk level [Morse Fall Scale] 03-27-2019
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 03-27-2019
Observation Total score [AUDIT-C] 03-27-2019
Procedure Medication Reconciliation (procedure) 03-27-2019
Procedure Assessment of health and social care needs (procedure) 03-27-2019
Procedure Assessment of anxiety (procedure) 03-27-2019
Procedure Assessment using Morse Fall Scale (procedure) 03-27-2019
Procedure Depression screening (procedure) 03-27-2019
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 03-27-2019
Procedure Assessment of substance use (procedure) 03-27-2019
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 03-27-2019
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 03-27-2019
Encounter Encounter for check up (procedure) 05-22-2019
Observation Glucose [Mass/volume] in Serum or Plasma 05-22-2019
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 05-22-2019
Observation Creatinine [Mass/volume] in Serum or Plasma 05-22-2019
Observation Calcium [Mass/volume] in Serum or Plasma 05-22-2019
Observation Sodium [Moles/volume] in Serum or Plasma 05-22-2019
Observation Potassium [Moles/volume] in Serum or Plasma 05-22-2019
Observation Chloride [Moles/volume] in Serum or Plasma 05-22-2019
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 05-22-2019
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 05-22-2019
Observation Appearance of Urine 05-22-2019
Observation Odor of Urine 05-22-2019
Observation Clarity of Urine 05-22-2019
Observation Color of Urine 05-22-2019
Observation Glucose [Mass/volume] in Urine by Test strip 05-22-2019
Observation Glucose [Presence] in Urine by Test strip 05-22-2019
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 05-22-2019
Observation Bilirubin.total [Presence] in Urine by Test strip 05-22-2019
Observation Ketones [Mass/volume] in Urine by Test strip 05-22-2019
Observation Ketones [Presence] in Urine by Test strip 05-22-2019
Observation Specific gravity of Urine by Test strip 05-22-2019
Observation pH of Urine by Test strip 05-22-2019
Observation Protein [Mass/volume] in Urine by Test strip 05-22-2019
Observation Protein [Presence] in Urine by Test strip 05-22-2019
Observation Nitrite [Presence] in Urine by Test strip 05-22-2019
Observation Hemoglobin [Presence] in Urine by Test strip 05-22-2019
Observation Leukocyte esterase [Presence] in Urine by Test strip 05-22-2019
Observation Body Height 05-22-2019
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 05-22-2019
Observation Body Weight 05-22-2019
Observation Body mass index (BMI) [Ratio] 05-22-2019
Observation Blood pressure panel with all children optional 05-22-2019
Observation Heart rate 05-22-2019
Observation Respiratory rate 05-22-2019
Observation Tobacco smoking status 05-22-2019
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 05-22-2019
Observation Fall risk total [Morse Fall Scale] 05-22-2019
Observation Fall risk level [Morse Fall Scale] 05-22-2019
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 05-22-2019
Observation Total score [AUDIT-C] 05-22-2019
Procedure Assessment of health and social care needs (procedure) 05-22-2019
Procedure Assessment using Morse Fall Scale (procedure) 05-22-2019
Procedure Depression screening (procedure) 05-22-2019
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 05-22-2019
Procedure Assessment of substance use (procedure) 05-22-2019
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 05-22-2019
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 05-22-2019
Encounter Encounter for check up (procedure) 09-18-2019
Observation Glucose [Mass/volume] in Serum or Plasma 09-18-2019
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 09-18-2019
Observation Creatinine [Mass/volume] in Serum or Plasma 09-18-2019
Observation Calcium [Mass/volume] in Serum or Plasma 09-18-2019
Observation Sodium [Moles/volume] in Serum or Plasma 09-18-2019
Observation Potassium [Moles/volume] in Serum or Plasma 09-18-2019
Observation Chloride [Moles/volume] in Serum or Plasma 09-18-2019
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 09-18-2019
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 09-18-2019
Observation Appearance of Urine 09-18-2019
Observation Odor of Urine 09-18-2019
Observation Clarity of Urine 09-18-2019
Observation Color of Urine 09-18-2019
Observation Glucose [Mass/volume] in Urine by Test strip 09-18-2019
Observation Glucose [Presence] in Urine by Test strip 09-18-2019
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 09-18-2019
Observation Bilirubin.total [Presence] in Urine by Test strip 09-18-2019
Observation Ketones [Mass/volume] in Urine by Test strip 09-18-2019
Observation Ketones [Presence] in Urine by Test strip 09-18-2019
Observation Specific gravity of Urine by Test strip 09-18-2019
Observation pH of Urine by Test strip 09-18-2019
Observation Protein [Mass/volume] in Urine by Test strip 09-18-2019
Observation Protein [Presence] in Urine by Test strip 09-18-2019
Observation Nitrite [Presence] in Urine by Test strip 09-18-2019
Observation Hemoglobin [Presence] in Urine by Test strip 09-18-2019
Observation Leukocyte esterase [Presence] in Urine by Test strip 09-18-2019
Observation Body Height 09-18-2019
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 09-18-2019
Observation Body Weight 09-18-2019
Observation Body mass index (BMI) [Ratio] 09-18-2019
Observation Blood pressure panel with all children optional 09-18-2019
Observation Heart rate 09-18-2019
Observation Respiratory rate 09-18-2019
Observation Tobacco smoking status 09-18-2019
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 09-18-2019
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 09-18-2019
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 09-18-2019
Observation Total score [DAST-10] 09-18-2019
Procedure Medication Reconciliation (procedure) 09-18-2019
Procedure Assessment of health and social care needs (procedure) 09-18-2019
Procedure Assessment of anxiety (procedure) 09-18-2019
Procedure Depression screening (procedure) 09-18-2019
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 09-18-2019
Procedure Assessment of substance use (procedure) 09-18-2019
Procedure Screening for drug abuse (procedure) 09-18-2019
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 09-18-2019
Encounter General examination of patient (procedure) 02-26-2020
Observation Glucose [Mass/volume] in Serum or Plasma 02-26-2020
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 02-26-2020
Observation Creatinine [Mass/volume] in Serum or Plasma 02-26-2020
Observation Calcium [Mass/volume] in Serum or Plasma 02-26-2020
Observation Sodium [Moles/volume] in Serum or Plasma 02-26-2020
Observation Potassium [Moles/volume] in Serum or Plasma 02-26-2020
Observation Chloride [Moles/volume] in Serum or Plasma 02-26-2020
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 02-26-2020
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 02-26-2020
Observation Appearance of Urine 02-26-2020
Observation Odor of Urine 02-26-2020
Observation Clarity of Urine 02-26-2020
Observation Color of Urine 02-26-2020
Observation Glucose [Mass/volume] in Urine by Test strip 02-26-2020
Observation Glucose [Presence] in Urine by Test strip 02-26-2020
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 02-26-2020
Observation Bilirubin.total [Presence] in Urine by Test strip 02-26-2020
Observation Ketones [Mass/volume] in Urine by Test strip 02-26-2020
Observation Ketones [Presence] in Urine by Test strip 02-26-2020
Observation Specific gravity of Urine by Test strip 02-26-2020
Observation pH of Urine by Test strip 02-26-2020
Observation Protein [Mass/volume] in Urine by Test strip 02-26-2020
Observation Protein [Presence] in Urine by Test strip 02-26-2020
Observation Nitrite [Presence] in Urine by Test strip 02-26-2020
Observation Hemoglobin [Presence] in Urine by Test strip 02-26-2020
Observation Leukocyte esterase [Presence] in Urine by Test strip 02-26-2020
Observation Body Height 02-26-2020
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 02-26-2020
Observation Body Weight 02-26-2020
Observation Body mass index (BMI) [Ratio] 02-26-2020
Observation Blood pressure panel with all children optional 02-26-2020
Observation Heart rate 02-26-2020
Observation Respiratory rate 02-26-2020
Observation Tobacco smoking status 02-26-2020
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 02-26-2020
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 02-26-2020
Observation Fall risk total [Morse Fall Scale] 02-26-2020
Observation Fall risk level [Morse Fall Scale] 02-26-2020
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 02-26-2020
Observation Total score [AUDIT-C] 02-26-2020
Procedure Assessment of health and social care needs (procedure) 02-26-2020
Procedure Assessment of anxiety (procedure) 02-26-2020
Procedure Assessment using Morse Fall Scale (procedure) 02-26-2020
Procedure Depression screening (procedure) 02-26-2020
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 02-26-2020
Procedure Assessment of substance use (procedure) 02-26-2020
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 02-26-2020
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 02-26-2020
Immunization Influenza, seasonal, injectable, preservative free 02-26-2020
Encounter Emergency room admission (procedure) 07-02-2020
MedicationRequest Naproxen sodium 220 MG Oral Tablet 07-02-2020
Encounter Encounter for check up (procedure) 07-15-2020
Observation Glucose [Mass/volume] in Serum or Plasma 07-15-2020
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 07-15-2020
Observation Creatinine [Mass/volume] in Serum or Plasma 07-15-2020
Observation Calcium [Mass/volume] in Serum or Plasma 07-15-2020
Observation Sodium [Moles/volume] in Serum or Plasma 07-15-2020
Observation Potassium [Moles/volume] in Serum or Plasma 07-15-2020
Observation Chloride [Moles/volume] in Serum or Plasma 07-15-2020
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 07-15-2020
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 07-15-2020
Observation Appearance of Urine 07-15-2020
Observation Odor of Urine 07-15-2020
Observation Clarity of Urine 07-15-2020
Observation Color of Urine 07-15-2020
Observation Glucose [Mass/volume] in Urine by Test strip 07-15-2020
Observation Glucose [Presence] in Urine by Test strip 07-15-2020
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 07-15-2020
Observation Bilirubin.total [Presence] in Urine by Test strip 07-15-2020
Observation Ketones [Mass/volume] in Urine by Test strip 07-15-2020
Observation Ketones [Presence] in Urine by Test strip 07-15-2020
Observation Specific gravity of Urine by Test strip 07-15-2020
Observation pH of Urine by Test strip 07-15-2020
Observation Protein [Mass/volume] in Urine by Test strip 07-15-2020
Observation Protein [Presence] in Urine by Test strip 07-15-2020
Observation Nitrite [Presence] in Urine by Test strip 07-15-2020
Observation Hemoglobin [Presence] in Urine by Test strip 07-15-2020
Observation Leukocyte esterase [Presence] in Urine by Test strip 07-15-2020
Observation Body Height 07-15-2020
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 07-15-2020
Observation Body Weight 07-15-2020
Observation Body mass index (BMI) [Ratio] 07-15-2020
Observation Blood pressure panel with all children optional 07-15-2020
Observation Heart rate 07-15-2020
Observation Respiratory rate 07-15-2020
Observation Tobacco smoking status 07-15-2020
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 07-15-2020
Observation Fall risk total [Morse Fall Scale] 07-15-2020
Observation Fall risk level [Morse Fall Scale] 07-15-2020
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 07-15-2020
Observation Total score [AUDIT-C] 07-15-2020
Procedure Assessment of health and social care needs (procedure) 07-15-2020
Procedure Assessment using Morse Fall Scale (procedure) 07-15-2020
Procedure Depression screening (procedure) 07-15-2020
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 07-15-2020
Procedure Assessment of substance use (procedure) 07-15-2020
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 07-15-2020
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 07-15-2020
Encounter Encounter for check up (procedure) 11-11-2020
Observation Glucose [Mass/volume] in Serum or Plasma 11-11-2020
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 11-11-2020
Observation Creatinine [Mass/volume] in Serum or Plasma 11-11-2020
Observation Calcium [Mass/volume] in Serum or Plasma 11-11-2020
Observation Sodium [Moles/volume] in Serum or Plasma 11-11-2020
Observation Potassium [Moles/volume] in Serum or Plasma 11-11-2020
Observation Chloride [Moles/volume] in Serum or Plasma 11-11-2020
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 11-11-2020
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 11-11-2020
Observation Appearance of Urine 11-11-2020
Observation Odor of Urine 11-11-2020
Observation Clarity of Urine 11-11-2020
Observation Color of Urine 11-11-2020
Observation Glucose [Mass/volume] in Urine by Test strip 11-11-2020
Observation Glucose [Presence] in Urine by Test strip 11-11-2020
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 11-11-2020
Observation Bilirubin.total [Presence] in Urine by Test strip 11-11-2020
Observation Ketones [Mass/volume] in Urine by Test strip 11-11-2020
Observation Ketones [Presence] in Urine by Test strip 11-11-2020
Observation Specific gravity of Urine by Test strip 11-11-2020
Observation pH of Urine by Test strip 11-11-2020
Observation Protein [Mass/volume] in Urine by Test strip 11-11-2020
Observation Protein [Presence] in Urine by Test strip 11-11-2020
Observation Nitrite [Presence] in Urine by Test strip 11-11-2020
Observation Hemoglobin [Presence] in Urine by Test strip 11-11-2020
Observation Leukocyte esterase [Presence] in Urine by Test strip 11-11-2020
Observation Body Height 11-11-2020
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 11-11-2020
Observation Body Weight 11-11-2020
Observation Body mass index (BMI) [Ratio] 11-11-2020
Observation Blood pressure panel with all children optional 11-11-2020
Observation Heart rate 11-11-2020
Observation Respiratory rate 11-11-2020
Observation Tobacco smoking status 11-11-2020
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 11-11-2020
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 11-11-2020
Observation Fall risk total [Morse Fall Scale] 11-11-2020
Observation Fall risk level [Morse Fall Scale] 11-11-2020
Observation Total score [HARK] 11-11-2020
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 11-11-2020
Observation Total score [DAST-10] 11-11-2020
Procedure Assessment of health and social care needs (procedure) 11-11-2020
Procedure Assessment of anxiety (procedure) 11-11-2020
Procedure Assessment using Morse Fall Scale (procedure) 11-11-2020
Procedure Screening for domestic abuse (procedure) 11-11-2020
Procedure Depression screening (procedure) 11-11-2020
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 11-11-2020
Procedure Assessment of substance use (procedure) 11-11-2020
Procedure Screening for drug abuse (procedure) 11-11-2020
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 11-11-2020
Immunization Influenza, seasonal, injectable, preservative free 11-11-2020
Encounter Encounter for check up (procedure) 12-16-2020
Observation Glucose [Mass/volume] in Serum or Plasma 12-16-2020
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 12-16-2020
Observation Creatinine [Mass/volume] in Serum or Plasma 12-16-2020
Observation Calcium [Mass/volume] in Serum or Plasma 12-16-2020
Observation Sodium [Moles/volume] in Serum or Plasma 12-16-2020
Observation Potassium [Moles/volume] in Serum or Plasma 12-16-2020
Observation Chloride [Moles/volume] in Serum or Plasma 12-16-2020
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 12-16-2020
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 12-16-2020
Observation Appearance of Urine 12-16-2020
Observation Odor of Urine 12-16-2020
Observation Clarity of Urine 12-16-2020
Observation Color of Urine 12-16-2020
Observation Glucose [Mass/volume] in Urine by Test strip 12-16-2020
Observation Glucose [Presence] in Urine by Test strip 12-16-2020
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 12-16-2020
Observation Bilirubin.total [Presence] in Urine by Test strip 12-16-2020
Observation Ketones [Mass/volume] in Urine by Test strip 12-16-2020
Observation Ketones [Presence] in Urine by Test strip 12-16-2020
Observation Specific gravity of Urine by Test strip 12-16-2020
Observation pH of Urine by Test strip 12-16-2020
Observation Protein [Mass/volume] in Urine by Test strip 12-16-2020
Observation Protein [Presence] in Urine by Test strip 12-16-2020
Observation Nitrite [Presence] in Urine by Test strip 12-16-2020
Observation Hemoglobin [Presence] in Urine by Test strip 12-16-2020
Observation Leukocyte esterase [Presence] in Urine by Test strip 12-16-2020
Observation Body Height 12-16-2020
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 12-16-2020
Observation Body Weight 12-16-2020
Observation Body mass index (BMI) [Ratio] 12-16-2020
Observation Blood pressure panel with all children optional 12-16-2020
Observation Heart rate 12-16-2020
Observation Respiratory rate 12-16-2020
Observation Tobacco smoking status 12-16-2020
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 12-16-2020
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 12-16-2020
Observation Total score [DAST-10] 12-16-2020
Procedure Medication Reconciliation (procedure) 12-16-2020
Procedure Assessment of health and social care needs (procedure) 12-16-2020
Procedure Depression screening (procedure) 12-16-2020
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 12-16-2020
Procedure Assessment of substance use (procedure) 12-16-2020
Procedure Screening for drug abuse (procedure) 12-16-2020
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 12-16-2020
Encounter General examination of patient (procedure) 03-03-2021
Observation Glucose [Mass/volume] in Serum or Plasma 03-03-2021
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 03-03-2021
Observation Creatinine [Mass/volume] in Serum or Plasma 03-03-2021
Observation Calcium [Mass/volume] in Serum or Plasma 03-03-2021
Observation Sodium [Moles/volume] in Serum or Plasma 03-03-2021
Observation Potassium [Moles/volume] in Serum or Plasma 03-03-2021
Observation Chloride [Moles/volume] in Serum or Plasma 03-03-2021
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 03-03-2021
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 03-03-2021
Observation Appearance of Urine 03-03-2021
Observation Odor of Urine 03-03-2021
Observation Clarity of Urine 03-03-2021
Observation Color of Urine 03-03-2021
Observation Glucose [Mass/volume] in Urine by Test strip 03-03-2021
Observation Glucose [Presence] in Urine by Test strip 03-03-2021
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 03-03-2021
Observation Bilirubin.total [Presence] in Urine by Test strip 03-03-2021
Observation Ketones [Mass/volume] in Urine by Test strip 03-03-2021
Observation Ketones [Presence] in Urine by Test strip 03-03-2021
Observation Specific gravity of Urine by Test strip 03-03-2021
Observation pH of Urine by Test strip 03-03-2021
Observation Protein [Mass/volume] in Urine by Test strip 03-03-2021
Observation Protein [Presence] in Urine by Test strip 03-03-2021
Observation Nitrite [Presence] in Urine by Test strip 03-03-2021
Observation Hemoglobin [Presence] in Urine by Test strip 03-03-2021
Observation Leukocyte esterase [Presence] in Urine by Test strip 03-03-2021
Observation Body Height 03-03-2021
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 03-03-2021
Observation Body Weight 03-03-2021
Observation Body mass index (BMI) [Ratio] 03-03-2021
Observation Blood pressure panel with all children optional 03-03-2021
Observation Heart rate 03-03-2021
Observation Respiratory rate 03-03-2021
Observation Cholesterol [Mass/volume] in Serum or Plasma 03-03-2021
Observation Triglycerides 03-03-2021
Observation Low Density Lipoprotein Cholesterol 03-03-2021
Observation Cholesterol in HDL [Mass/volume] in Serum or Plasma 03-03-2021
Observation Tobacco smoking status 03-03-2021
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 03-03-2021
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 03-03-2021
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 03-03-2021
Observation Total score [AUDIT-C] 03-03-2021
Procedure Assessment of health and social care needs (procedure) 03-03-2021
Procedure Assessment of anxiety (procedure) 03-03-2021
Procedure Depression screening (procedure) 03-03-2021
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 03-03-2021
Procedure Assessment of substance use (procedure) 03-03-2021
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 03-03-2021
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 03-03-2021
Immunization SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose 03-03-2021
Encounter Encounter for check up (procedure) 03-10-2021
Observation Glucose [Mass/volume] in Serum or Plasma 03-10-2021
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 03-10-2021
Observation Creatinine [Mass/volume] in Serum or Plasma 03-10-2021
Observation Calcium [Mass/volume] in Serum or Plasma 03-10-2021
Observation Sodium [Moles/volume] in Serum or Plasma 03-10-2021
Observation Potassium [Moles/volume] in Serum or Plasma 03-10-2021
Observation Chloride [Moles/volume] in Serum or Plasma 03-10-2021
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 03-10-2021
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 03-10-2021
Observation Appearance of Urine 03-10-2021
Observation Odor of Urine 03-10-2021
Observation Clarity of Urine 03-10-2021
Observation Color of Urine 03-10-2021
Observation Glucose [Mass/volume] in Urine by Test strip 03-10-2021
Observation Glucose [Presence] in Urine by Test strip 03-10-2021
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 03-10-2021
Observation Bilirubin.total [Presence] in Urine by Test strip 03-10-2021
Observation Ketones [Mass/volume] in Urine by Test strip 03-10-2021
Observation Ketones [Presence] in Urine by Test strip 03-10-2021
Observation Specific gravity of Urine by Test strip 03-10-2021
Observation pH of Urine by Test strip 03-10-2021
Observation Protein [Mass/volume] in Urine by Test strip 03-10-2021
Observation Protein [Presence] in Urine by Test strip 03-10-2021
Observation Nitrite [Presence] in Urine by Test strip 03-10-2021
Observation Hemoglobin [Presence] in Urine by Test strip 03-10-2021
Observation Leukocyte esterase [Presence] in Urine by Test strip 03-10-2021
Procedure Medication Reconciliation (procedure) 03-10-2021
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 03-10-2021
Encounter Administration of vaccine to produce active immunity (procedure) 03-24-2021
Immunization SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose 03-24-2021
Encounter Encounter for check up (procedure) 04-14-2021
Observation Glucose [Mass/volume] in Serum or Plasma 04-14-2021
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 04-14-2021
Observation Creatinine [Mass/volume] in Serum or Plasma 04-14-2021
Observation Calcium [Mass/volume] in Serum or Plasma 04-14-2021
Observation Sodium [Moles/volume] in Serum or Plasma 04-14-2021
Observation Potassium [Moles/volume] in Serum or Plasma 04-14-2021
Observation Chloride [Moles/volume] in Serum or Plasma 04-14-2021
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 04-14-2021
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 04-14-2021
Observation Appearance of Urine 04-14-2021
Observation Odor of Urine 04-14-2021
Observation Clarity of Urine 04-14-2021
Observation Color of Urine 04-14-2021
Observation Glucose [Mass/volume] in Urine by Test strip 04-14-2021
Observation Glucose [Presence] in Urine by Test strip 04-14-2021
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 04-14-2021
Observation Bilirubin.total [Presence] in Urine by Test strip 04-14-2021
Observation Ketones [Mass/volume] in Urine by Test strip 04-14-2021
Observation Ketones [Presence] in Urine by Test strip 04-14-2021
Observation Specific gravity of Urine by Test strip 04-14-2021
Observation pH of Urine by Test strip 04-14-2021
Observation Protein [Mass/volume] in Urine by Test strip 04-14-2021
Observation Protein [Presence] in Urine by Test strip 04-14-2021
Observation Nitrite [Presence] in Urine by Test strip 04-14-2021
Observation Hemoglobin [Presence] in Urine by Test strip 04-14-2021
Observation Leukocyte esterase [Presence] in Urine by Test strip 04-14-2021
Observation Body Height 04-14-2021
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 04-14-2021
Observation Body Weight 04-14-2021
Observation Body mass index (BMI) [Ratio] 04-14-2021
Observation Blood pressure panel with all children optional 04-14-2021
Observation Heart rate 04-14-2021
Observation Respiratory rate 04-14-2021
Observation Tobacco smoking status 04-14-2021
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 04-14-2021
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 04-14-2021
Observation Total score [HARK] 04-14-2021
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 04-14-2021
Observation Total score [AUDIT-C] 04-14-2021
Procedure Medication Reconciliation (procedure) 04-14-2021
Procedure Assessment of health and social care needs (procedure) 04-14-2021
Procedure Assessment of anxiety (procedure) 04-14-2021
Procedure Screening for domestic abuse (procedure) 04-14-2021
Procedure Depression screening (procedure) 04-14-2021
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 04-14-2021
Procedure Assessment of substance use (procedure) 04-14-2021
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 04-14-2021
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 04-14-2021
Encounter Encounter for check up (procedure) 08-11-2021
Observation Glucose [Mass/volume] in Serum or Plasma 08-11-2021
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 08-11-2021
Observation Creatinine [Mass/volume] in Serum or Plasma 08-11-2021
Observation Calcium [Mass/volume] in Serum or Plasma 08-11-2021
Observation Sodium [Moles/volume] in Serum or Plasma 08-11-2021
Observation Potassium [Moles/volume] in Serum or Plasma 08-11-2021
Observation Chloride [Moles/volume] in Serum or Plasma 08-11-2021
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 08-11-2021
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 08-11-2021
Observation Appearance of Urine 08-11-2021
Observation Odor of Urine 08-11-2021
Observation Clarity of Urine 08-11-2021
Observation Color of Urine 08-11-2021
Observation Glucose [Mass/volume] in Urine by Test strip 08-11-2021
Observation Glucose [Presence] in Urine by Test strip 08-11-2021
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 08-11-2021
Observation Bilirubin.total [Presence] in Urine by Test strip 08-11-2021
Observation Ketones [Mass/volume] in Urine by Test strip 08-11-2021
Observation Ketones [Presence] in Urine by Test strip 08-11-2021
Observation Specific gravity of Urine by Test strip 08-11-2021
Observation pH of Urine by Test strip 08-11-2021
Observation Protein [Mass/volume] in Urine by Test strip 08-11-2021
Observation Protein [Presence] in Urine by Test strip 08-11-2021
Observation Nitrite [Presence] in Urine by Test strip 08-11-2021
Observation Hemoglobin [Presence] in Urine by Test strip 08-11-2021
Observation Leukocyte esterase [Presence] in Urine by Test strip 08-11-2021
Observation Body Height 08-11-2021
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 08-11-2021
Observation Body Weight 08-11-2021
Observation Body mass index (BMI) [Ratio] 08-11-2021
Observation Blood pressure panel with all children optional 08-11-2021
Observation Heart rate 08-11-2021
Observation Respiratory rate 08-11-2021
Observation Tobacco smoking status 08-11-2021
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 08-11-2021
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 08-11-2021
Observation Fall risk total [Morse Fall Scale] 08-11-2021
Observation Fall risk level [Morse Fall Scale] 08-11-2021
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 08-11-2021
Observation Total score [AUDIT-C] 08-11-2021
Procedure Medication Reconciliation (procedure) 08-11-2021
Procedure Assessment of health and social care needs (procedure) 08-11-2021
Procedure Assessment of anxiety (procedure) 08-11-2021
Procedure Assessment using Morse Fall Scale (procedure) 08-11-2021
Procedure Depression screening (procedure) 08-11-2021
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 08-11-2021
Procedure Assessment of substance use (procedure) 08-11-2021
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 08-11-2021
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 08-11-2021
Encounter Encounter for check up (procedure) 10-06-2021
Observation Glucose [Mass/volume] in Serum or Plasma 10-06-2021
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 10-06-2021
Observation Creatinine [Mass/volume] in Serum or Plasma 10-06-2021
Observation Calcium [Mass/volume] in Serum or Plasma 10-06-2021
Observation Sodium [Moles/volume] in Serum or Plasma 10-06-2021
Observation Potassium [Moles/volume] in Serum or Plasma 10-06-2021
Observation Chloride [Moles/volume] in Serum or Plasma 10-06-2021
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 10-06-2021
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 10-06-2021
Observation Appearance of Urine 10-06-2021
Observation Odor of Urine 10-06-2021
Observation Clarity of Urine 10-06-2021
Observation Color of Urine 10-06-2021
Observation Glucose [Mass/volume] in Urine by Test strip 10-06-2021
Observation Glucose [Presence] in Urine by Test strip 10-06-2021
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 10-06-2021
Observation Bilirubin.total [Presence] in Urine by Test strip 10-06-2021
Observation Ketones [Mass/volume] in Urine by Test strip 10-06-2021
Observation Ketones [Presence] in Urine by Test strip 10-06-2021
Observation Specific gravity of Urine by Test strip 10-06-2021
Observation pH of Urine by Test strip 10-06-2021
Observation Protein [Mass/volume] in Urine by Test strip 10-06-2021
Observation Protein [Presence] in Urine by Test strip 10-06-2021
Observation Nitrite [Presence] in Urine by Test strip 10-06-2021
Observation Hemoglobin [Presence] in Urine by Test strip 10-06-2021
Observation Leukocyte esterase [Presence] in Urine by Test strip 10-06-2021
Observation Body Height 10-06-2021
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 10-06-2021
Observation Body Weight 10-06-2021
Observation Body mass index (BMI) [Ratio] 10-06-2021
Observation Blood pressure panel with all children optional 10-06-2021
Observation Heart rate 10-06-2021
Observation Respiratory rate 10-06-2021
Observation Tobacco smoking status 10-06-2021
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 10-06-2021
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 10-06-2021
Observation Fall risk total [Morse Fall Scale] 10-06-2021
Observation Fall risk level [Morse Fall Scale] 10-06-2021
Observation Total score [HARK] 10-06-2021
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 10-06-2021
Observation Total score [AUDIT-C] 10-06-2021
Procedure Medication Reconciliation (procedure) 10-06-2021
Procedure Assessment of health and social care needs (procedure) 10-06-2021
Procedure Assessment of anxiety (procedure) 10-06-2021
Procedure Assessment using Morse Fall Scale (procedure) 10-06-2021
Procedure Screening for domestic abuse (procedure) 10-06-2021
Procedure Depression screening (procedure) 10-06-2021
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 10-06-2021
Procedure Assessment of substance use (procedure) 10-06-2021
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 10-06-2021
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 10-06-2021
Immunization Influenza, seasonal, injectable, preservative free 10-06-2021
Encounter Emergency room admission (procedure) 12-22-2021
Observation Glucose [Mass/volume] in Serum or Plasma 12-22-2021
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 12-22-2021
Observation Creatinine [Mass/volume] in Serum or Plasma 12-22-2021
Observation Calcium [Mass/volume] in Serum or Plasma 12-22-2021
Observation Sodium [Moles/volume] in Serum or Plasma 12-22-2021
Observation Potassium [Moles/volume] in Serum or Plasma 12-22-2021
Observation Chloride [Moles/volume] in Serum or Plasma 12-22-2021
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 12-22-2021
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 12-22-2021
Observation Appearance of Urine 12-22-2021
Observation Odor of Urine 12-22-2021
Observation Clarity of Urine 12-22-2021
Observation Color of Urine 12-22-2021
Observation Glucose [Mass/volume] in Urine by Test strip 12-22-2021
Observation Glucose [Presence] in Urine by Test strip 12-22-2021
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 12-22-2021
Observation Bilirubin.total [Presence] in Urine by Test strip 12-22-2021
Observation Ketones [Mass/volume] in Urine by Test strip 12-22-2021
Observation Ketones [Presence] in Urine by Test strip 12-22-2021
Observation Specific gravity of Urine by Test strip 12-22-2021
Observation pH of Urine by Test strip 12-22-2021
Observation Protein [Mass/volume] in Urine by Test strip 12-22-2021
Observation Protein [Presence] in Urine by Test strip 12-22-2021
Observation Nitrite [Presence] in Urine by Test strip 12-22-2021
Observation Hemoglobin [Presence] in Urine by Test strip 12-22-2021
Observation Leukocyte esterase [Presence] in Urine by Test strip 12-22-2021
Observation Body Height 12-22-2021
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 12-22-2021
Observation Body Weight 12-22-2021
Observation Body mass index (BMI) [Ratio] 12-22-2021
Observation Blood pressure panel with all children optional 12-22-2021
Observation Heart rate 12-22-2021
Observation Respiratory rate 12-22-2021
Observation Tobacco smoking status 12-22-2021
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 12-22-2021
Observation Fall risk total [Morse Fall Scale] 12-22-2021
Observation Fall risk level [Morse Fall Scale] 12-22-2021
Observation Total score [AUDIT-C] 12-22-2021
Procedure Assessment of health and social care needs (procedure) 12-22-2021
Procedure Assessment using Morse Fall Scale (procedure) 12-22-2021
Procedure Assessment of substance use (procedure) 12-22-2021
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 12-22-2021
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 12-22-2021
Encounter Urgent care clinic (environment) 12-29-2021
Observation Glucose [Mass/volume] in Serum or Plasma 12-29-2021
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 12-29-2021
Observation Creatinine [Mass/volume] in Serum or Plasma 12-29-2021
Observation Calcium [Mass/volume] in Serum or Plasma 12-29-2021
Observation Sodium [Moles/volume] in Serum or Plasma 12-29-2021
Observation Potassium [Moles/volume] in Serum or Plasma 12-29-2021
Observation Chloride [Moles/volume] in Serum or Plasma 12-29-2021
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 12-29-2021
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 12-29-2021
Observation Appearance of Urine 12-29-2021
Observation Odor of Urine 12-29-2021
Observation Clarity of Urine 12-29-2021
Observation Color of Urine 12-29-2021
Observation Glucose [Mass/volume] in Urine by Test strip 12-29-2021
Observation Glucose [Presence] in Urine by Test strip 12-29-2021
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 12-29-2021
Observation Bilirubin.total [Presence] in Urine by Test strip 12-29-2021
Observation Ketones [Mass/volume] in Urine by Test strip 12-29-2021
Observation Ketones [Presence] in Urine by Test strip 12-29-2021
Observation Specific gravity of Urine by Test strip 12-29-2021
Observation pH of Urine by Test strip 12-29-2021
Observation Protein [Mass/volume] in Urine by Test strip 12-29-2021
Observation Protein [Presence] in Urine by Test strip 12-29-2021
Observation Nitrite [Presence] in Urine by Test strip 12-29-2021
Observation Hemoglobin [Presence] in Urine by Test strip 12-29-2021
Observation Leukocyte esterase [Presence] in Urine by Test strip 12-29-2021
Procedure Medication Reconciliation (procedure) 12-29-2021
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 12-29-2021
Encounter Urgent care clinic (environment) 01-05-2022
Observation Glucose [Mass/volume] in Serum or Plasma 01-05-2022
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 01-05-2022
Observation Creatinine [Mass/volume] in Serum or Plasma 01-05-2022
Observation Calcium [Mass/volume] in Serum or Plasma 01-05-2022
Observation Sodium [Moles/volume] in Serum or Plasma 01-05-2022
Observation Potassium [Moles/volume] in Serum or Plasma 01-05-2022
Observation Chloride [Moles/volume] in Serum or Plasma 01-05-2022
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 01-05-2022
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 01-05-2022
Observation Appearance of Urine 01-05-2022
Observation Odor of Urine 01-05-2022
Observation Clarity of Urine 01-05-2022
Observation Color of Urine 01-05-2022
Observation Glucose [Mass/volume] in Urine by Test strip 01-05-2022
Observation Glucose [Presence] in Urine by Test strip 01-05-2022
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 01-05-2022
Observation Bilirubin.total [Presence] in Urine by Test strip 01-05-2022
Observation Ketones [Mass/volume] in Urine by Test strip 01-05-2022
Observation Ketones [Presence] in Urine by Test strip 01-05-2022
Observation Specific gravity of Urine by Test strip 01-05-2022
Observation pH of Urine by Test strip 01-05-2022
Observation Protein [Mass/volume] in Urine by Test strip 01-05-2022
Observation Protein [Presence] in Urine by Test strip 01-05-2022
Observation Nitrite [Presence] in Urine by Test strip 01-05-2022
Observation Hemoglobin [Presence] in Urine by Test strip 01-05-2022
Observation Leukocyte esterase [Presence] in Urine by Test strip 01-05-2022
Observation Body Height 01-05-2022
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 01-05-2022
Observation Body Weight 01-05-2022
Observation Body mass index (BMI) [Ratio] 01-05-2022
Observation Blood pressure panel with all children optional 01-05-2022
Observation Heart rate 01-05-2022
Observation Respiratory rate 01-05-2022
Observation Tobacco smoking status 01-05-2022
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 01-05-2022
Observation Fall risk total [Morse Fall Scale] 01-05-2022
Observation Fall risk level [Morse Fall Scale] 01-05-2022
Observation Total score [HARK] 01-05-2022
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 01-05-2022
Procedure Assessment of health and social care needs (procedure) 01-05-2022
Procedure Assessment using Morse Fall Scale (procedure) 01-05-2022
Procedure Screening for domestic abuse (procedure) 01-05-2022
Procedure Depression screening (procedure) 01-05-2022
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 01-05-2022
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 01-05-2022
Encounter Encounter for check up (procedure) 01-12-2022
Observation Glucose [Mass/volume] in Serum or Plasma 01-12-2022
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 01-12-2022
Observation Creatinine [Mass/volume] in Serum or Plasma 01-12-2022
Observation Calcium [Mass/volume] in Serum or Plasma 01-12-2022
Observation Sodium [Moles/volume] in Serum or Plasma 01-12-2022
Observation Potassium [Moles/volume] in Serum or Plasma 01-12-2022
Observation Chloride [Moles/volume] in Serum or Plasma 01-12-2022
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 01-12-2022
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 01-12-2022
Observation Appearance of Urine 01-12-2022
Observation Odor of Urine 01-12-2022
Observation Clarity of Urine 01-12-2022
Observation Color of Urine 01-12-2022
Observation Glucose [Mass/volume] in Urine by Test strip 01-12-2022
Observation Glucose [Presence] in Urine by Test strip 01-12-2022
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 01-12-2022
Observation Bilirubin.total [Presence] in Urine by Test strip 01-12-2022
Observation Ketones [Mass/volume] in Urine by Test strip 01-12-2022
Observation Ketones [Presence] in Urine by Test strip 01-12-2022
Observation Specific gravity of Urine by Test strip 01-12-2022
Observation pH of Urine by Test strip 01-12-2022
Observation Protein [Mass/volume] in Urine by Test strip 01-12-2022
Observation Protein [Presence] in Urine by Test strip 01-12-2022
Observation Nitrite [Presence] in Urine by Test strip 01-12-2022
Observation Hemoglobin [Presence] in Urine by Test strip 01-12-2022
Observation Leukocyte esterase [Presence] in Urine by Test strip 01-12-2022
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 01-12-2022
Encounter Encounter for symptom 01-19-2022
MedicationRequest Amoxicillin 250 MG / Clavulanate 125 MG Oral Tablet 01-19-2022
Encounter Urgent care clinic (environment) 02-09-2022
Observation Glucose [Mass/volume] in Serum or Plasma 02-09-2022
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 02-09-2022
Observation Creatinine [Mass/volume] in Serum or Plasma 02-09-2022
Observation Calcium [Mass/volume] in Serum or Plasma 02-09-2022
Observation Sodium [Moles/volume] in Serum or Plasma 02-09-2022
Observation Potassium [Moles/volume] in Serum or Plasma 02-09-2022
Observation Chloride [Moles/volume] in Serum or Plasma 02-09-2022
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 02-09-2022
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 02-09-2022
Observation Appearance of Urine 02-09-2022
Observation Odor of Urine 02-09-2022
Observation Clarity of Urine 02-09-2022
Observation Color of Urine 02-09-2022
Observation Glucose [Mass/volume] in Urine by Test strip 02-09-2022
Observation Glucose [Presence] in Urine by Test strip 02-09-2022
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 02-09-2022
Observation Bilirubin.total [Presence] in Urine by Test strip 02-09-2022
Observation Ketones [Mass/volume] in Urine by Test strip 02-09-2022
Observation Ketones [Presence] in Urine by Test strip 02-09-2022
Observation Specific gravity of Urine by Test strip 02-09-2022
Observation pH of Urine by Test strip 02-09-2022
Observation Protein [Mass/volume] in Urine by Test strip 02-09-2022
Observation Protein [Presence] in Urine by Test strip 02-09-2022
Observation Nitrite [Presence] in Urine by Test strip 02-09-2022
Observation Hemoglobin [Presence] in Urine by Test strip 02-09-2022
Observation Leukocyte esterase [Presence] in Urine by Test strip 02-09-2022
Observation Body Height 02-09-2022
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 02-09-2022
Observation Body Weight 02-09-2022
Observation Body mass index (BMI) [Ratio] 02-09-2022
Observation Blood pressure panel with all children optional 02-09-2022
Observation Heart rate 02-09-2022
Observation Respiratory rate 02-09-2022
Observation Tobacco smoking status 02-09-2022
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 02-09-2022
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 02-09-2022
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 02-09-2022
Observation Total score [AUDIT-C] 02-09-2022
Procedure Medication Reconciliation (procedure) 02-09-2022
Procedure Assessment of health and social care needs (procedure) 02-09-2022
Procedure Assessment of anxiety (procedure) 02-09-2022
Procedure Depression screening (procedure) 02-09-2022
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 02-09-2022
Procedure Assessment of substance use (procedure) 02-09-2022
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 02-09-2022
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 02-09-2022
Encounter Encounter for check up (procedure) 02-16-2022
Observation Glucose [Mass/volume] in Serum or Plasma 02-16-2022
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 02-16-2022
Observation Creatinine [Mass/volume] in Serum or Plasma 02-16-2022
Observation Calcium [Mass/volume] in Serum or Plasma 02-16-2022
Observation Sodium [Moles/volume] in Serum or Plasma 02-16-2022
Observation Potassium [Moles/volume] in Serum or Plasma 02-16-2022
Observation Chloride [Moles/volume] in Serum or Plasma 02-16-2022
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 02-16-2022
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 02-16-2022
Observation Appearance of Urine 02-16-2022
Observation Odor of Urine 02-16-2022
Observation Clarity of Urine 02-16-2022
Observation Color of Urine 02-16-2022
Observation Glucose [Mass/volume] in Urine by Test strip 02-16-2022
Observation Glucose [Presence] in Urine by Test strip 02-16-2022
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 02-16-2022
Observation Bilirubin.total [Presence] in Urine by Test strip 02-16-2022
Observation Ketones [Mass/volume] in Urine by Test strip 02-16-2022
Observation Ketones [Presence] in Urine by Test strip 02-16-2022
Observation Specific gravity of Urine by Test strip 02-16-2022
Observation pH of Urine by Test strip 02-16-2022
Observation Protein [Mass/volume] in Urine by Test strip 02-16-2022
Observation Protein [Presence] in Urine by Test strip 02-16-2022
Observation Nitrite [Presence] in Urine by Test strip 02-16-2022
Observation Hemoglobin [Presence] in Urine by Test strip 02-16-2022
Observation Leukocyte esterase [Presence] in Urine by Test strip 02-16-2022
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 02-16-2022
Encounter General examination of patient (procedure) 03-09-2022
Condition Social isolation (finding) 03-09-2022
Observation Glucose [Mass/volume] in Serum or Plasma 03-09-2022
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 03-09-2022
Observation Creatinine [Mass/volume] in Serum or Plasma 03-09-2022
Observation Calcium [Mass/volume] in Serum or Plasma 03-09-2022
Observation Sodium [Moles/volume] in Serum or Plasma 03-09-2022
Observation Potassium [Moles/volume] in Serum or Plasma 03-09-2022
Observation Chloride [Moles/volume] in Serum or Plasma 03-09-2022
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 03-09-2022
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 03-09-2022
Observation Appearance of Urine 03-09-2022
Observation Odor of Urine 03-09-2022
Observation Clarity of Urine 03-09-2022
Observation Color of Urine 03-09-2022
Observation Glucose [Mass/volume] in Urine by Test strip 03-09-2022
Observation Glucose [Presence] in Urine by Test strip 03-09-2022
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 03-09-2022
Observation Bilirubin.total [Presence] in Urine by Test strip 03-09-2022
Observation Ketones [Mass/volume] in Urine by Test strip 03-09-2022
Observation Ketones [Presence] in Urine by Test strip 03-09-2022
Observation Specific gravity of Urine by Test strip 03-09-2022
Observation pH of Urine by Test strip 03-09-2022
Observation Protein [Mass/volume] in Urine by Test strip 03-09-2022
Observation Protein [Presence] in Urine by Test strip 03-09-2022
Observation Nitrite [Presence] in Urine by Test strip 03-09-2022
Observation Hemoglobin [Presence] in Urine by Test strip 03-09-2022
Observation Leukocyte esterase [Presence] in Urine by Test strip 03-09-2022
Observation Body Height 03-09-2022
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 03-09-2022
Observation Body Weight 03-09-2022
Observation Body mass index (BMI) [Ratio] 03-09-2022
Observation Blood pressure panel with all children optional 03-09-2022
Observation Heart rate 03-09-2022
Observation Respiratory rate 03-09-2022
Observation Tobacco smoking status 03-09-2022
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 03-09-2022
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 03-09-2022
Procedure Assessment of health and social care needs (procedure) 03-09-2022
Procedure Depression screening (procedure) 03-09-2022
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 03-09-2022
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 03-09-2022
Encounter Encounter for check up (procedure) 06-08-2022
Observation Glucose [Mass/volume] in Serum or Plasma 06-08-2022
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 06-08-2022
Observation Creatinine [Mass/volume] in Serum or Plasma 06-08-2022
Observation Calcium [Mass/volume] in Serum or Plasma 06-08-2022
Observation Sodium [Moles/volume] in Serum or Plasma 06-08-2022
Observation Potassium [Moles/volume] in Serum or Plasma 06-08-2022
Observation Chloride [Moles/volume] in Serum or Plasma 06-08-2022
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 06-08-2022
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 06-08-2022
Observation Appearance of Urine 06-08-2022
Observation Odor of Urine 06-08-2022
Observation Clarity of Urine 06-08-2022
Observation Color of Urine 06-08-2022
Observation Glucose [Mass/volume] in Urine by Test strip 06-08-2022
Observation Glucose [Presence] in Urine by Test strip 06-08-2022
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 06-08-2022
Observation Bilirubin.total [Presence] in Urine by Test strip 06-08-2022
Observation Ketones [Mass/volume] in Urine by Test strip 06-08-2022
Observation Ketones [Presence] in Urine by Test strip 06-08-2022
Observation Specific gravity of Urine by Test strip 06-08-2022
Observation pH of Urine by Test strip 06-08-2022
Observation Protein [Mass/volume] in Urine by Test strip 06-08-2022
Observation Protein [Presence] in Urine by Test strip 06-08-2022
Observation Nitrite [Presence] in Urine by Test strip 06-08-2022
Observation Hemoglobin [Presence] in Urine by Test strip 06-08-2022
Observation Leukocyte esterase [Presence] in Urine by Test strip 06-08-2022
Observation Body Height 06-08-2022
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 06-08-2022
Observation Body Weight 06-08-2022
Observation Body mass index (BMI) [Ratio] 06-08-2022
Observation Blood pressure panel with all children optional 06-08-2022
Observation Heart rate 06-08-2022
Observation Respiratory rate 06-08-2022
Observation Tobacco smoking status 06-08-2022
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 06-08-2022
Observation Total score [HARK] 06-08-2022
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 06-08-2022
Observation Total score [AUDIT-C] 06-08-2022
Procedure Assessment of health and social care needs (procedure) 06-08-2022
Procedure Screening for domestic abuse (procedure) 06-08-2022
Procedure Depression screening (procedure) 06-08-2022
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 06-08-2022
Procedure Assessment of substance use (procedure) 06-08-2022
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 06-08-2022
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 06-08-2022
Immunization Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed 06-08-2022
Encounter Encounter for check up (procedure) 07-06-2022
Observation Glucose [Mass/volume] in Serum or Plasma 07-06-2022
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 07-06-2022
Observation Creatinine [Mass/volume] in Serum or Plasma 07-06-2022
Observation Calcium [Mass/volume] in Serum or Plasma 07-06-2022
Observation Sodium [Moles/volume] in Serum or Plasma 07-06-2022
Observation Potassium [Moles/volume] in Serum or Plasma 07-06-2022
Observation Chloride [Moles/volume] in Serum or Plasma 07-06-2022
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 07-06-2022
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 07-06-2022
Observation Appearance of Urine 07-06-2022
Observation Odor of Urine 07-06-2022
Observation Clarity of Urine 07-06-2022
Observation Color of Urine 07-06-2022
Observation Glucose [Mass/volume] in Urine by Test strip 07-06-2022
Observation Glucose [Presence] in Urine by Test strip 07-06-2022
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 07-06-2022
Observation Bilirubin.total [Presence] in Urine by Test strip 07-06-2022
Observation Ketones [Mass/volume] in Urine by Test strip 07-06-2022
Observation Ketones [Presence] in Urine by Test strip 07-06-2022
Observation Specific gravity of Urine by Test strip 07-06-2022
Observation pH of Urine by Test strip 07-06-2022
Observation Protein [Mass/volume] in Urine by Test strip 07-06-2022
Observation Protein [Presence] in Urine by Test strip 07-06-2022
Observation Nitrite [Presence] in Urine by Test strip 07-06-2022
Observation Hemoglobin [Presence] in Urine by Test strip 07-06-2022
Observation Leukocyte esterase [Presence] in Urine by Test strip 07-06-2022
Observation Body Height 07-06-2022
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 07-06-2022
Observation Body Weight 07-06-2022
Observation Body mass index (BMI) [Ratio] 07-06-2022
Observation Blood pressure panel with all children optional 07-06-2022
Observation Heart rate 07-06-2022
Observation Respiratory rate 07-06-2022
Observation Tobacco smoking status 07-06-2022
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 07-06-2022
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 07-06-2022
Observation Fall risk total [Morse Fall Scale] 07-06-2022
Observation Fall risk level [Morse Fall Scale] 07-06-2022
Observation Total score [AUDIT-C] 07-06-2022
Procedure Assessment of health and social care needs (procedure) 07-06-2022
Procedure Assessment of anxiety (procedure) 07-06-2022
Procedure Assessment using Morse Fall Scale (procedure) 07-06-2022
Procedure Assessment of substance use (procedure) 07-06-2022
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 07-06-2022
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 07-06-2022
Encounter Encounter for check up (procedure) 08-03-2022
Observation Glucose [Mass/volume] in Serum or Plasma 08-03-2022
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 08-03-2022
Observation Creatinine [Mass/volume] in Serum or Plasma 08-03-2022
Observation Calcium [Mass/volume] in Serum or Plasma 08-03-2022
Observation Sodium [Moles/volume] in Serum or Plasma 08-03-2022
Observation Potassium [Moles/volume] in Serum or Plasma 08-03-2022
Observation Chloride [Moles/volume] in Serum or Plasma 08-03-2022
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 08-03-2022
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 08-03-2022
Observation Appearance of Urine 08-03-2022
Observation Odor of Urine 08-03-2022
Observation Clarity of Urine 08-03-2022
Observation Color of Urine 08-03-2022
Observation Glucose [Mass/volume] in Urine by Test strip 08-03-2022
Observation Glucose [Presence] in Urine by Test strip 08-03-2022
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 08-03-2022
Observation Bilirubin.total [Presence] in Urine by Test strip 08-03-2022
Observation Ketones [Mass/volume] in Urine by Test strip 08-03-2022
Observation Ketones [Presence] in Urine by Test strip 08-03-2022
Observation Specific gravity of Urine by Test strip 08-03-2022
Observation pH of Urine by Test strip 08-03-2022
Observation Protein [Mass/volume] in Urine by Test strip 08-03-2022
Observation Protein [Presence] in Urine by Test strip 08-03-2022
Observation Nitrite [Presence] in Urine by Test strip 08-03-2022
Observation Hemoglobin [Presence] in Urine by Test strip 08-03-2022
Observation Leukocyte esterase [Presence] in Urine by Test strip 08-03-2022
Observation Body Height 08-03-2022
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 08-03-2022
Observation Body Weight 08-03-2022
Observation Body mass index (BMI) [Ratio] 08-03-2022
Observation Blood pressure panel with all children optional 08-03-2022
Observation Heart rate 08-03-2022
Observation Respiratory rate 08-03-2022
Observation Tobacco smoking status 08-03-2022
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 08-03-2022
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 08-03-2022
Observation Fall risk total [Morse Fall Scale] 08-03-2022
Observation Fall risk level [Morse Fall Scale] 08-03-2022
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 08-03-2022
Observation Total score [AUDIT-C] 08-03-2022
Procedure Medication Reconciliation (procedure) 08-03-2022
Procedure Assessment of health and social care needs (procedure) 08-03-2022
Procedure Assessment of anxiety (procedure) 08-03-2022
Procedure Assessment using Morse Fall Scale (procedure) 08-03-2022
Procedure Depression screening (procedure) 08-03-2022
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 08-03-2022
Procedure Assessment of substance use (procedure) 08-03-2022
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 08-03-2022
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 08-03-2022
Encounter Encounter for check up (procedure) 10-05-2022
Observation Glucose [Mass/volume] in Serum or Plasma 10-05-2022
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 10-05-2022
Observation Creatinine [Mass/volume] in Serum or Plasma 10-05-2022
Observation Calcium [Mass/volume] in Serum or Plasma 10-05-2022
Observation Sodium [Moles/volume] in Serum or Plasma 10-05-2022
Observation Potassium [Moles/volume] in Serum or Plasma 10-05-2022
Observation Chloride [Moles/volume] in Serum or Plasma 10-05-2022
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 10-05-2022
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 10-05-2022
Observation Appearance of Urine 10-05-2022
Observation Odor of Urine 10-05-2022
Observation Clarity of Urine 10-05-2022
Observation Color of Urine 10-05-2022
Observation Glucose [Mass/volume] in Urine by Test strip 10-05-2022
Observation Glucose [Presence] in Urine by Test strip 10-05-2022
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 10-05-2022
Observation Bilirubin.total [Presence] in Urine by Test strip 10-05-2022
Observation Ketones [Mass/volume] in Urine by Test strip 10-05-2022
Observation Ketones [Presence] in Urine by Test strip 10-05-2022
Observation Specific gravity of Urine by Test strip 10-05-2022
Observation pH of Urine by Test strip 10-05-2022
Observation Protein [Mass/volume] in Urine by Test strip 10-05-2022
Observation Protein [Presence] in Urine by Test strip 10-05-2022
Observation Nitrite [Presence] in Urine by Test strip 10-05-2022
Observation Hemoglobin [Presence] in Urine by Test strip 10-05-2022
Observation Leukocyte esterase [Presence] in Urine by Test strip 10-05-2022
Observation Body Height 10-05-2022
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 10-05-2022
Observation Body Weight 10-05-2022
Observation Body mass index (BMI) [Ratio] 10-05-2022
Observation Blood pressure panel with all children optional 10-05-2022
Observation Heart rate 10-05-2022
Observation Respiratory rate 10-05-2022
Observation Tobacco smoking status 10-05-2022
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 10-05-2022
Observation Fall risk total [Morse Fall Scale] 10-05-2022
Observation Fall risk level [Morse Fall Scale] 10-05-2022
Observation Total score [DAST-10] 10-05-2022
Procedure Medication Reconciliation (procedure) 10-05-2022
Procedure Assessment of health and social care needs (procedure) 10-05-2022
Procedure Assessment using Morse Fall Scale (procedure) 10-05-2022
Procedure Assessment of substance use (procedure) 10-05-2022
Procedure Screening for drug abuse (procedure) 10-05-2022
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 10-05-2022
Immunization Influenza, seasonal, injectable, preservative free 10-05-2022
Encounter Encounter for check up (procedure) 01-04-2023
Condition Full-time employment (finding) 01-04-2023
Observation Glucose [Mass/volume] in Serum or Plasma 01-04-2023
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 01-04-2023
Observation Creatinine [Mass/volume] in Serum or Plasma 01-04-2023
Observation Calcium [Mass/volume] in Serum or Plasma 01-04-2023
Observation Sodium [Moles/volume] in Serum or Plasma 01-04-2023
Observation Potassium [Moles/volume] in Serum or Plasma 01-04-2023
Observation Chloride [Moles/volume] in Serum or Plasma 01-04-2023
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 01-04-2023
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 01-04-2023
Observation Appearance of Urine 01-04-2023
Observation Odor of Urine 01-04-2023
Observation Clarity of Urine 01-04-2023
Observation Color of Urine 01-04-2023
Observation Glucose [Mass/volume] in Urine by Test strip 01-04-2023
Observation Glucose [Presence] in Urine by Test strip 01-04-2023
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 01-04-2023
Observation Bilirubin.total [Presence] in Urine by Test strip 01-04-2023
Observation Ketones [Mass/volume] in Urine by Test strip 01-04-2023
Observation Ketones [Presence] in Urine by Test strip 01-04-2023
Observation Specific gravity of Urine by Test strip 01-04-2023
Observation pH of Urine by Test strip 01-04-2023
Observation Protein [Mass/volume] in Urine by Test strip 01-04-2023
Observation Protein [Presence] in Urine by Test strip 01-04-2023
Observation Nitrite [Presence] in Urine by Test strip 01-04-2023
Observation Hemoglobin [Presence] in Urine by Test strip 01-04-2023
Observation Leukocyte esterase [Presence] in Urine by Test strip 01-04-2023
Observation Body Height 01-04-2023
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 01-04-2023
Observation Body Weight 01-04-2023
Observation Body mass index (BMI) [Ratio] 01-04-2023
Observation Blood pressure panel with all children optional 01-04-2023
Observation Heart rate 01-04-2023
Observation Respiratory rate 01-04-2023
Observation Tobacco smoking status 01-04-2023
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 01-04-2023
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 01-04-2023
Observation Fall risk total [Morse Fall Scale] 01-04-2023
Observation Fall risk level [Morse Fall Scale] 01-04-2023
Observation Total score [AUDIT-C] 01-04-2023
Procedure Medication Reconciliation (procedure) 01-04-2023
Procedure Assessment of health and social care needs (procedure) 01-04-2023
Procedure Assessment of anxiety (procedure) 01-04-2023
Procedure Assessment using Morse Fall Scale (procedure) 01-04-2023
Procedure Assessment of substance use (procedure) 01-04-2023
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 01-04-2023
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 01-04-2023
Encounter General examination of patient (procedure) 03-15-2023
Condition Medication review due (situation) 03-15-2023
Observation Glucose [Mass/volume] in Serum or Plasma 03-15-2023
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 03-15-2023
Observation Creatinine [Mass/volume] in Serum or Plasma 03-15-2023
Observation Calcium [Mass/volume] in Serum or Plasma 03-15-2023
Observation Sodium [Moles/volume] in Serum or Plasma 03-15-2023
Observation Potassium [Moles/volume] in Serum or Plasma 03-15-2023
Observation Chloride [Moles/volume] in Serum or Plasma 03-15-2023
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 03-15-2023
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 03-15-2023
Observation Appearance of Urine 03-15-2023
Observation Odor of Urine 03-15-2023
Observation Clarity of Urine 03-15-2023
Observation Color of Urine 03-15-2023
Observation Glucose [Mass/volume] in Urine by Test strip 03-15-2023
Observation Glucose [Presence] in Urine by Test strip 03-15-2023
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 03-15-2023
Observation Bilirubin.total [Presence] in Urine by Test strip 03-15-2023
Observation Ketones [Mass/volume] in Urine by Test strip 03-15-2023
Observation Ketones [Presence] in Urine by Test strip 03-15-2023
Observation Specific gravity of Urine by Test strip 03-15-2023
Observation pH of Urine by Test strip 03-15-2023
Observation Protein [Mass/volume] in Urine by Test strip 03-15-2023
Observation Protein [Presence] in Urine by Test strip 03-15-2023
Observation Nitrite [Presence] in Urine by Test strip 03-15-2023
Observation Hemoglobin [Presence] in Urine by Test strip 03-15-2023
Observation Leukocyte esterase [Presence] in Urine by Test strip 03-15-2023
Observation Body Height 03-15-2023
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 03-15-2023
Observation Body Weight 03-15-2023
Observation Body mass index (BMI) [Ratio] 03-15-2023
Observation Blood pressure panel with all children optional 03-15-2023
Observation Heart rate 03-15-2023
Observation Respiratory rate 03-15-2023
Observation Tobacco smoking status 03-15-2023
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 03-15-2023
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 03-15-2023
Observation Total score [AUDIT-C] 03-15-2023
Procedure Assessment of health and social care needs (procedure) 03-15-2023
Procedure Assessment of anxiety (procedure) 03-15-2023
Procedure Assessment of substance use (procedure) 03-15-2023
Procedure Assessment using Alcohol Use Disorders Identification Test - Consumption (procedure) 03-15-2023
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 03-15-2023
Encounter Urgent care clinic (environment) 09-27-2023
Observation Glucose [Mass/volume] in Serum or Plasma 09-27-2023
Observation Urea nitrogen [Mass/volume] in Serum or Plasma 09-27-2023
Observation Creatinine [Mass/volume] in Serum or Plasma 09-27-2023
Observation Calcium [Mass/volume] in Serum or Plasma 09-27-2023
Observation Sodium [Moles/volume] in Serum or Plasma 09-27-2023
Observation Potassium [Moles/volume] in Serum or Plasma 09-27-2023
Observation Chloride [Moles/volume] in Serum or Plasma 09-27-2023
Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma 09-27-2023
Observation Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 09-27-2023
Observation Appearance of Urine 09-27-2023
Observation Odor of Urine 09-27-2023
Observation Clarity of Urine 09-27-2023
Observation Color of Urine 09-27-2023
Observation Glucose [Mass/volume] in Urine by Test strip 09-27-2023
Observation Glucose [Presence] in Urine by Test strip 09-27-2023
Observation Bilirubin.total [Mass/volume] in Urine by Test strip 09-27-2023
Observation Bilirubin.total [Presence] in Urine by Test strip 09-27-2023
Observation Ketones [Mass/volume] in Urine by Test strip 09-27-2023
Observation Ketones [Presence] in Urine by Test strip 09-27-2023
Observation Specific gravity of Urine by Test strip 09-27-2023
Observation pH of Urine by Test strip 09-27-2023
Observation Protein [Mass/volume] in Urine by Test strip 09-27-2023
Observation Protein [Presence] in Urine by Test strip 09-27-2023
Observation Nitrite [Presence] in Urine by Test strip 09-27-2023
Observation Hemoglobin [Presence] in Urine by Test strip 09-27-2023
Observation Leukocyte esterase [Presence] in Urine by Test strip 09-27-2023
Observation Body Height 09-27-2023
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 09-27-2023
Observation Body Weight 09-27-2023
Observation Body mass index (BMI) [Ratio] 09-27-2023
Observation Blood pressure panel with all children optional 09-27-2023
Observation Heart rate 09-27-2023
Observation Respiratory rate 09-27-2023
Observation Tobacco smoking status 09-27-2023
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 09-27-2023
Observation Fall risk total [Morse Fall Scale] 09-27-2023
Observation Fall risk level [Morse Fall Scale] 09-27-2023
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 09-27-2023
Observation Total score [DAST-10] 09-27-2023
Procedure Assessment of health and social care needs (procedure) 09-27-2023
Procedure Assessment using Morse Fall Scale (procedure) 09-27-2023
Procedure Depression screening (procedure) 09-27-2023
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 09-27-2023
Procedure Assessment of substance use (procedure) 09-27-2023
Procedure Screening for drug abuse (procedure) 09-27-2023
MedicationRequest Hydrochlorothiazide 25 MG Oral Tablet 09-27-2023
Encounter Emergency room admission (procedure) 10-31-2023
Condition Sprain (morphologic abnormality) 10-31-2023
Condition Sprain of ankle 10-31-2023
MedicationRequest Acetaminophen 325 MG Oral Tablet 10-31-2023
